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ABSTRACT 
In this study, we assayed the capability of four genes implicated in embryonic specification of 
the cortico-cerebral field, Foxg1, Pax6, Emx2 and Lhx2, to reprogramm mouse embryonic 
fibroblasts toward neural identities. Lentivirus-mediated, TetON-dependent overexpression of 
Pax6 and Foxg1 transgenes specifically activated the neural stem cell (NSC) reporter Sox1-EGFP 
in a substantial fraction of engineered cells. The efficiency of this process was enhanced up to 
ten times by simultaneous inactivation of  Trp53 and co-administration of a specific drug mix 
inhibiting HDACs, H3K27-HMTase and H3K4m2-demethylase. Remarkably, a fraction of the 
reprogrammed population expressed other NSC markers and retained its new identity, even 
upon transgenes switching off. When transferred into a pro-differentiative environment, 
Pax6/Foxg1-overexpressing cells activated the neuronal marker Tau-EGFP. Frequency of Tau-
EGFP cells was almost doubled upon delayed delivery of Emx2 and Lhx2 transgenes. A further 
improvement of the neuron-like cells output was achieved by tonic inhibition of BMP and TGFb 
pathways. These Tau-EGFP cells showed a negative resting potential and displayed active 
electric responses, following injection of depolarizing currents. 
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CHAPTER 1. INTRODUCTION : CENTRAL NERVOUS SYSTEM PATTERNING 
 
During early embryogenesis, the ectoderm is induced to form the nervous system and the 
epidermis. A portion of the dorsal ectoderm is specified to become neural ectoderm, and its 
cells become distinguishable by their columnar appearance. This region of the embryo is called 
the neural plate. The process by which this tissue forms a neural tube (fig.1), the rudiment of 
the central nervous system, is called neurulation, and an embryo undergoing such changes is 
called a neurula. Rostral and caudal neural tube will form the brain and the spinal cord, 
respectively. 
 
 
Figure 1. Schematic view of the neural tube formation and the signaling sources involved. 
1) opened neural plate; 2) neural grove formation; 3) closed the neural tube; 4) delaminating neuralcrests. 
 
 
 
1.1. Neurulation and primaryRostro/Caudal Patterning 
 
The embryonic precursor of the brain is a planar sheet of pseudostratified neuroepithelium 
produced during gastrulation, known as the neural plate. The neural plate is induced by the 
underlying mesoderm. The neuroepithelial cells acquire distinct properties depending on the 
positions within the CNS primordium to yield divergent neuronal cells types at specific 
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locations. The neural plate is subdivided into molecularly distinct domains with characteristic 
locations. 
Primary determination of the neural plate and of its main subdivisions is promoted to large 
extent by a wide set of factors, released by the underlying mesoderm. For example, the 
inhibition of ectodermal BMP signaling promoted by Cerberus, Chordin, Noggin, Follistatin 
allows general neuroectoderm to revert to its neural ground state. Inhibition of Wnt8a 
signalling and activation of Fgf signalling contribute to neural induction as well. This model, 
developed originally for Xenopus laevis, seems to be basically valid for all vertebrates(fig.2). 
 
 
Figure 2. Model of determination of the neural plate in Xenopus laevis(adapted from Gilbert, Developmental 
Biology). 
 
As mentioned above, the process of neurulation converts the neural plate into the neural tube 
(E7.5 in mouse). 
The early mammalian neural tube is a straight structure. However, even before the posterior 
portion of the tube has formed, the most anterior portion of the tube is undergoing drammatic 
changes. In this region, a series of ring-like constrictions mark the approximate boundaries 
between the primordia of the major brain regions (or primary vesicles) (Fig.3): forebrain 
(prosencephalon), midbrain (mesencephalon), and hindbrain (rhombencephalon). 
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Fig. 3.Early human brain development. Left: primary brain vescicles. Right: adult derivative formed by the walls 
and cavities of the brain(adapted from Gilbert, Developmental Biology). 
 
 
 
The prosencephalon becomes subdivided into the anterior telencephalon and the more caudal 
diencephalon(fig.3).As a result of early R-C and D-V patterning events , the dorsal 
telencephalon (the pallium) will give rise to the archicortex (subiculum, hippocampus and 
dentate gyrus), the paleocortex (olfactory piriform cortex and enthorinal cortex) and the 
neocortex(fig.4). The ventral telencephalon (or subpallium) is further subdivided into two main 
domains, called basal ganglia: the more ventrally located is the medial ganglionic eminence 
(MGE), precursors of the globus pallidum, the more dorsal is the lateral ganglionic eminence 
(LGE), which generates the striatum. A third eminence called caudal ganglionic eminence (CGE) 
supplies for the amigdala (Fig. 4). 
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Figure 4. (A) Schematic view of a coronal section through the developing mousetelencephalic vesicle at E12. (B) 
Sagittal view of the embryonic vertebrate telencephalon as a transparent structure to reveal the ganglionic 
eminences CGE, caudal ganglionic eminence; CTX, cortex; LGE, lateral ganglionic eminence; MGE, medial ganglionic 
eminence; OB, olfactory bulb. Images modified from Molyneaux, Nature Reviews Neuroscience 8, 427-437 (June 
2007) | doi:10.1038/nrn2151 (A) and Corbin,Nat Neurosci. 2001 Nov;4 Suppl:1177-82(B). 
 
The diencephalon will form the thalamic and hypothalamic brain regions that receive neural 
inputs from a variety of structures, including the retina. Indeed, the retina itself is a derivative 
of the diencephalon. The mesencephalon does not become subdivided, and its lumen becomes 
the cerebral aqueduct. The rhombencephalon becomes subdivided into a posterior 
myelencephalon and a more anterior metencephalon (fig.3). 
 
 
 
1.2.Anterior-Posterior Patterning in the Neural Tube: organizers, transcription 
factors and small molecules 
The first and most evident process occurring in the mouse developing nervoussystem from E8.5 
is the regionalization along the antero-posterior axis (A/P). By E10.0 forebrain, midbrain, 
hindbrain and spinal cord domains are formed. The patterning of this region is associated with 
precise antero-posterior expression domains or gradients of several regulatory genes coding for 
transcription factors. 
11 
 
The regionalization process bases on the activity of primary and secondary “organizers”. The 
early patterning of anterior and posterior neural tissues is mediated troughsignals released by 
the primitive node or organizer, known as Hensen’s node in chick, and Spemnann organizer in 
frog. In general, the so called neural-plate organizers are signaling center located in different 
positions and established to maintain and further refine positional cell identities along the A/P 
axis of the neural plate 
1
. They produce signals that influence cellular fate, histogenic 
organization and growth of adjacent tissue in a position-specific manner. 
Patterning starts when markers expressed throughout the early neural plateultimately become 
restricted to anterior domains of the central nervous system andmolecules, including the Wnts, 
fibroblast growth factors (FGFs) and retinoids (RA), startto function at this stage of 
development to induce posterior character in the neural plate
2
.  
The  early R-C patterning of the anterior neural tissue (also known as “anteriorneural 
induction”) starts at E7 and  is mediated by antagonistic signals coming from 2 important 
primary organizers: the primitive node(Hensen’s node in the chicken) and the anterior visceral 
endoderm (AVE), required for neural induction and maintenance
3
. 
 
 
Figure7.Anterior- posterior patterning of the telencephalon, neural induction. 
Signals that come from the node establish gross anterior pattern (black arrow). The anterior visceral endoderm 
(AVE), together with the early node, acts to induce and/or maintain anterior neural character. The AVE is located 
beneath the future neural plate and expresses molecules, such as cerberus and dickkopf (red arrows), that inhibit 
factors that would otherwise act to posteriorize the neural plate (Wnts, FGF, RA).( Adapted from Rallu et al.,Nature 
Reviews Neuroscience 3, 943-951 (December 2002) | doi:10.1038/nrn989). 
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The AVE is an extra-embryonictissue that underlies the neural plate and secrete antagonists of 
Wnt factors, fibroblast growth factor (Fgfs) family members as well as retinoicacid 
4,5
 (fig.7). 
Among them, major roles are played by Cerberus and Dickkopf,that act to maintain and 
stabilize the anterior neural plate character
6
(See Fig. 8). 
As a consequence of the Wnt signalling, two different domains are defined alongthe 
anteroposterior axis by the expression of two homeobox genes: Otx2 and Gbx2(fig.8A).TheOtx-
expressing region, rostrally located, will give rise to the forebrain and midbrain,whereas the 
Gbx2-expressing region, at caudal position, will develop into hindbrain andspinal cord. The 
boundary between them corresponds anatomically to the isthmus, anarrowing of the neural 
tube at the border between mesencephalon and metencephalon. 
Canonical Wnt signaling represses Otx2 expression, whereas induces Gbx2 (Fig. 8A). Wnts 
induce also the expression of other two genes, Irx3 and Six3, confining Six3 to the anteriormost 
neural territory and promoting posterior expression of Irx3, at levelscaudal to the presumptive 
zona limitans intrathalamica (ZLI), subsequently placed between thalamus and prethalamus. 
Upon anterior neural induction, two sources of Fgf molecules are established at the borders of 
the anterior neural field (fig.8).The ANB activity is at least partly carried by the secreted 
frizzled-related proteins (sFRP), such us TLc, acting as a Wnt antagonist. This suggested a 
general model, in which the default forebrain identity is posterior (diencephalic) and anterior 
telencephalic identity is achieved through antagonization of Wnt signaling by the AVE and ANR 
patterning centers. 
 
 
 
 
  
These “secondary organizers” are located
neural ectoderm (anterior neural ridge 
hindbrain fields, (i.e. at the isthmus
the anterior brain.  
The Anterior Neural Ridge is necessary for forebrain induction and maintenance. Ablation of the 
ANR in mice prevents the expression of the telencephalic markers Foxg1 and Emx1 
The ANR stimulates the expression of 
specification of the telencephalic
Fgf8 induction in the ANR , which in turn
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 at the junction between the anterior neural and non
or ANR)and at the boundary between midbrain and 
), respectively. Both are crucial to subsequent patterning of 
Foxg1, a key transcription factor implicated in R/C 
 field, via Fgf8 secretion. The ANB activity is responsible fo
 induces and/or maintains Foxg1. 
Figure 8. Schematic expression 
domains of the principal 
transcription factors involved in 
the antero/posterior patterning 
of the mouse central nervous 
system at E10.5. 
adapted from Mallamaci A, 
unpublished.
 
-
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The ZLI, deriving from the collapse of the region between Six3 and Irx3 
domains(Fig.8A),releases molecules of the Sonic hedgehog (Shh) family 
8
 and splits theanterior 
neural plate into two distinct domains, able to differentially respond to Fgfsignaling, expressing 
either Foxg1 or En2
9
. Remarkably, signalscoming from the ZLI induce expression of Gbx2 and 
Dlx2 in the thalamus and theprethalamus, respectively(Fig.8). 
Recent data suggest that in mammals also the Fgfs, secreted by the ANR, actively estabilish the 
telencephalic identity: when Fgf receptors are deleted the telencephalon does not form
10
. 
 
 
 
1.3.Dorsal-Ventral Patterning in the neural tube 
 
The polarity of the neural tube is induced by signals coming from itsimmediate environment. 
The dorsal pattern is imposed by the epidermis, while the ventral pattern is induced by the 
notochord (Fig.9). 
 
 
 
 
 
 
 
 
 
 
Figure 9. Dorsal-Ventral specification of the neural tube. (A)Two signalling centers influence the 
newly formed neural tube : the roof of the neural tube is exposed to BMP4 and  BMP7 from the 
epidermis,while the floor is exposed to Shh protein from the notochord. 
(B) Secondary signaling centers within the neural tube. The roof plate cells express and secrete 
BMP4, the floor plate are a source of Shh protein . 
(C) BMP4 establishes a cascade of TGF factor, diffusing from the roof plate to the ventral neural 
tube. Sonic hedhog proteins spread dorsally as a gradient from the floor plate cells. 
(D) The several  spinal cord neurons identities are established by  the exposure to BMP4/Shh 
gradients of paracrine factors. (Adapted from S. Gilbert). 
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1.3.1.Dorsal patterning of the neural tube 
 
The dorsal fates of the neural tube are established by proteins of the TGF-β superfamily, 
especially the bone morphogenetic proteins 4 and 7, dorsalin, and activin
11,12
. Initially, BMP4 
and BMP7 are found in the epidermis.As the notochord establishes a secondary signaling center 
(the floor plate cells) on the ventral side of the neural tube, the epidermis establishes a 
secondary signaling center by inducing BMP4 expression in the roof platecells of the neural 
tube. The BMP4 protein from the roof plate induces a cascade of TGF-β superfamily proteins in 
adjacent cells (Fig.9C). 
Different sets of cells are thus exposed to different concentrations of TGF-β superfamily 
proteins at different times (the most dorsal being exposed to more factors at higher 
concentrations and at earlier times). The temporal and concentration gradients of the TGF-β 
superfamily proteins induce different types of transcription factors in cells at different distances 
from the roof plate, thereby giving them different identities. 
 
 
1.3.2.Ventral patterning of the neural tube 
 
The specification of the ventral neural tube appears to be mediated by external tissues.One 
agent of ventral specification is the Sonic hedgehog protein, originating from the notochord. 
Another agent specifying the ventral neural cell types is retinoic acid, which probably comes 
from the adjacent somites 
13
.  
Sonic hedgehog establishes a gradient, and different levels of this protein cause the formation 
of different cell types. Sonic hedgehog is initially synthesized in the notochord.The secreted 
Sonic hedgehog induces the medial hinge cells to become the floor plate of the neural tube. 
These floor plate cells also secrete Sonic hedgehog, which forms a gradient highest at the most 
ventral portion of the neural tube 
14,15
. Those cells adjacent to the floor plate that receive high 
concentrations of Sonic hedgehog become the ventral (V3) neurons, while the next group of 
cells, exposed to slightly less Sonic hedgehog, become motor neurons (Fig.10). The next two 
groups of cells, receiving progressively less of this protein, become the V2 and V1 interneurons. 
  
 
 
 
 
1.3.3. Dorso-ventral specification 
Factors. 
 
The expression of transcription factors and secreted morphogenes along the D
early partitioning of the telencephalon that will end up with the specification of pallial and
subpallial structures. 
Among these factors, major roles are played by the dorsalizing Zinc
Gli3 and the ventralizing Winged helix transcription factor Foxg1 
effect of Gli3 is counteracted by Sonic hedgehog protein (Shh), secreted by the ventral midline: 
the telencephalon of Shh
-/- 
mice is reduced in size and ventral cell types lost. However, rescue 
of Shh
-/- 
phenotype in double Gli3
passes simply through inhibition of Gli3 activity. 
The earliest site of Shh expression appears at E7.5; as neurulation progresse
expressed by both prechordal plate and anterior mesoderm
hypothalamus and finally by the ventral telencephalon itself, from the medial ganglionic 
eminence together with the preoptic area
Figure 10.Induction of the ventral neural tube. 
notochord become floor plate neurons (in green);motor neurons originates 
from the ventro-lateral sides. (B) Relationship between Sonic hedgehog 
concentration and generation of different neuronal types 
from S.Gilbert). 
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in the telencephalon: Small Molecules and Transcription 
-finger transcription factor 
(Fig. 11A).
-/-
 Shh
-/- 
mice 
16
 suggests that the Shh role in this process 
 
 (Fig. 12A), then 
17
. Gli3 is induced by BMPs and is initially expressed 
(A) Cells closest to the 
in vitro.(Adapted 
-V axis elicits the 
 
 The dorsalizing 
s it is initially 
by the ventral 
 broadly throughout the telencephalic anlage
ventral portion of it. Shh signaling neutralize the repressive form of Gli3, blocking the 
conversion from the activator (Gli3) to the repressor (Gli3R) and, as a consequence, promoting 
Fgf expression. 
 
 
 
In absence of Gli3, the development of the dorsal telencephalon is disrupted
 Hence, Shh promotes ventral identity by preventing dorsalization of the telencephalon, rather 
than by directly promoting ventral cell character.
Ventral specification also requires the inhibition of dorsal signals by BMP antagonists, such as 
noggin (NOG) and chordin (CHRD).
by a Foxg1/Fgf pathway. Foxg1 induction inside the anterior neural plate depends on signals 
that initially regulate antero-posterior patterning. Fgfs secreted by the ANR serve as major 
telencephalic patterning signals throughout the forebrain development. Remarcably, when 
three Fgf receptors are deleted, the telencephalon is no longer specified 
 
 
 
17 
 and then is progressively downregulated in the 
 
18
. 
 
 The ventralizing signal in the forebrain is probably mediated 
10
. 
Figure 11. Dorso-ventral patterning of the 
forebrain. 
The region that will become the telencephalon is 
defined by expression of Foxg1. Foxg1 
and Shh (indirectly, via Gli3) promote Fgfs 
expression in the ANR. This patterns the nascent 
telencephalon. Dorsal view E8,E9 
Subsequently the dorsal telencephalon, 
expressing Gli3 at E9, is split, by E10, into a BMP 
and Wnt expressing medial region and a more 
lateral cortical regionex pressing countergradients 
of Emx2 and Pax6. The ventral telencephalon i
subdivided into medialNkx2.1-expressing domains 
and lateral Gsh2-expressing domains (partially 
overlapping at E10).Sagittal view E9, E10 
 
(directly) 
(A). 
s 
(B). 
18 
 
 
 
 
 
Forkhead box G1 (Foxg1) expression define the region that will become the telencephalon. 
Morever, Foxg1  promote Fgf expression, necessary to form all regions of the telencephalon. 
Disruption of Foxg1 expression results in a loss of ventral cell types 
19
.  
Mash1 and Ngn1/Ngn2 are proneural genes, that play important roles in thedevelopment of 
the ventral and dorsal telencephalon, respectively. However they do not act as “master genes”, 
but simply link regional patterning to activation of specific neuronogenetic pathways in these 
structures 
20,21
. 
 
 
- Molecular mechanisms mediating Forkhead box G1 role in D-V specification 
Foxg1(Forkhead box G1, formerly known as Bf-1) is expressed in the anterior neural plate cells 
from E8.5
22,23
, slightly before the neural plate bends to form the head folds. 
It is necessary for the expression of Fgfs from the ANR
19
 and in turn Fgf8 induces Foxg1 
expression
7,24
, forming a positive feedback loop. In Foxg1
-/- 
mice the formation of the 
subpallium is abolished(Xuan et al., Neuron, Voli. 14, 1141-1152, June, 1995). 
Figure12. Schematic view of early phases in dorso/ventral patterning of the rostral neural plate in 
the chick embryo. Image adapted from Mallamaci A, unpublished. 
19 
 
Remarkably, recent data in zebrafish suggest that Foxg1 could integrate signals from Shh, Wnt 
and Fgf8 pathways, so having a pivotal role in D-V forebrain specification. 
 
 
 
 
 
In fact,  Foxg1 could also act as a Wnt/β-catenin antagonist, as well as downstream effector of 
Shh to specify the subpallial identities 
25
. As a result of early R-C and D-V patterning events, the 
prosencephalon will be subdivided in pallial territories and subpallial territories, characterized 
by the expression of specific set of TFs. The subpallium will give riseto the medial ganglionic 
eminence (MGE) and to the lateral ganglionic eminence (LGE) , expressing respectively the TFs 
Nkx2.1 and Gsh2.  
Regarding the molecular mechanism, FoxG1 usually acts  as a transcriptional repressor in both  
direct andindirect ways
26–30
. 
Moreover, this factor can also inhibit TGFβ signalling by binding to Smadand FoxO transcription 
factors
27,31
(fig14). It was shown that  mouse Foxg1  proliferation-promoting effect ismediated 
by mechanisms based on protein-protein interactions and isnot dependent from its DNA-
binding ability 
27,32
. In contrast, Foxg1 requires an intact DNA-binding domain to 
inhibit or delay the neuronal differentiation of telencephalic precursor cells
32
. 
Figure 13.Forebrain development 
impairment in Foxg1-/- . 
Foxg1 knockouts display a smaller size of the 
telencephalic emispheres, if compared to 
heterozygous mice. The ventral telencephalon 
formation is heavily impaired, but also the 
dorsal telencephalon size is reduced. X-Gal 
histochemistry identifies structures that 
normally express Foxg1(Modified by Xuan  et 
al.,Neuron,Volume 14, Issue 6, June 1995, 
Pages 1141–1152). 
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Foxg1 exerts its transcriptional repressor activity, at least in part, through the recruitment  
transcriptional co-repressors of theGroucho/Transducin-like enhancer of split (TLE) and AT-
richinteraction domain (ARID) families 
30,33,34
. 
In turn,TLE and ARID co-repressors, recruit chromatin-modifying enzymes (i.e. histone 
deacetylases) to the transcription factor complex 
35
. In some cases, the co-repressor itself 
havedemethylation activity
36
. 
Specific TLEs are required for the activity of FoxG1 during forebrain development. In this regard, 
it was shown that when transfected in primary neural progenitors,FoxG1 acts as a repressor of 
cortical neurogenesis but this function can be enhanced by TLE1 or inverted by  TLE6 
37
.  
Foxg1 plays also a crucial role in ventral telencephalon formation. To carry out this function, 
Foxg1 physically interacts with another member of the TLE family ,TLE2. Either FoxG1 or TLE2 
knockdown abolishes or reduces the development of this region. The interaction between 
Foxg1 and TLE2 is mediated by aconserved Foxg1 N-terminal eh1 motif , whereas the C-
terminal domain,which has previously been suggested to contain a TLE binding motif,is not 
required
38
. However, the C-terminal domain isnecessary for the functional synergybetween 
FoxG1 and  TLE2, eitheralone or in combination with the N-terminal domain
38
. 
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- Other “Master genes” involved in dorso-ventral patterning of telencephalon 
Wnt and BMP expression (promoted by Gli3) are required for the expression of the empty 
spiracle homologsEmx1 and Emx2, confined to the primary proliferative layer of the cortex 
(Theil et al., 2002). Other transcription factors act subsequently to form specific 
subdivisions, such as Pax6, Gsh2 and Nkx2.1, crucial for the proper morphogenesis of the 
lateral cortex, striatum and anlage of globus pallidus respectively (Fig. 15). 
In the absence of any of them, the corresponding morphogenetic field is shrunken and the 
adjacent ones substantially enlarged 
39–41
. 
Pax6 and Gsh2 play complementary roles reciprocally compartmentalizing and establishing 
pallial and subpallial identities. In Pax6 null mice, there is a dorsal expansion of markers of 
ventral progenitors, such as Mash1, Gsh2 and Dlx2, whereas in Gsh2
-/-
it is the opposite 
20
. 
 
 
Figure 14. Model of FoxO Factors as a 
Node for Integration of TGF-_/Smad, 
PI3K/Akt, and FoxG1 Pathways.There are 
three  pathways converging on FoxO  to 
regulate the expression of p21Cip1 and cell 
proliferation. TGFβreceptor activation leads 
to Smad3 phosphorylation (P) and assembly 
of a Smad3- Smad4 complex in the nucleus. 
This complex associates with FoxO proteins 
and activatep21Cip1. 
IGF-1-like proliferative signals induce the 
PI3K/Akt pathway that in turn 
phosphorylates FoxO. This mechanism 
exclude FoxO  from the nucleus (Brunet et 
al., 1999) and prevent  Smad-FoxO 
dependent gene activation. FoxG1 binds to 
the FoxO-Smad complex, inhibiting its 
transcriptional activity (Adapted Joan 
Seoane et al.,Cell, Vol. 117, 211–223, April 
16, 2004). 
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In summary, the coordinate action of different signals including BMP/Wnt, RA,Fgf8 and Shh and 
the differential activation their targets in space and time establish theside where the pallium 
will develop and regulates its size. 
Some of these signalling systems and their targets are subsequently involved in 
furthersubdivision of the pallial anlage, in a process termed cortical regionalisation 
andarealization. 
 
 
 
1.4.Cortical specification and Arealization. 
 
The so-called arealization is a process that largely relies on the interplay between factors 
intrinsic to the cortical primordium and influences coming from subcortical structures.  
In particular, several experimental evidences suggests that cortex-autonomous molecular 
cuesdrive the early phases of arealization, independent of information delivered later by 
thalamic afferents.  
Cortical arealization starts at early stages (E10.5 in mouse), with the specification of a primitive 
molecular protomap, set up according to specific positional and temporal cues.  
The codification of these signals initiates intrinsically to the cortical field, resulting from the 
interplay between soluble factors, secreted at the borders of this field, and transcription factors 
expressed along tangential gradients within it. Subsequently, (E13.5 in mice) thalamo-cortical 
axons (TCA), relaying sensory information from distinct nuclei of the dorsal thalamus to 
Figure 15. Schematic representation of 
main transcription factors involved in 
regionalization of early cortical primordium. 
Corolan section of mouse telencephalon at 
E10. 
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different cortical regions, promote further inter-regional diversification, so leading to the 
properly called cortical arealization. 
The process of areal pattering depends on setting up rostrocaudal and  mediolateral gradients 
of TF expression, which are modulated by diffusible signals released by patterning centers at 
the edges of the cortical field. 
Hence, there are two main classes of molecules that play a crucial in the regionalization of the 
early cortical primordium:  
- secreted ligands (SLs), expressed  at the borders of the cortical field (Fig.17a), 
- and TFs, gradually expressed within the proliferative layers of this field (Fig.17b). 
Three specialized sources of SLs (also knownas”organizers”) may be found at the borders of the 
cortical field: the caudomedial cortical hem (between the hippocampal field and the choroidal 
field), the rostromedial commissural plate (between rostromedial cortex and septum) and the 
lateral cortical antihem (between the paleocortical and the striatal anlagen)(see fig. 16). 
The cortical hem is a source of Wnts (2b, 3a, 5b, 7a, 8b)
42
and Bmps (2, 4, 6, 7)
43
, expressed in 
nested domains which may include part of the adjacent cortical field. The formation of the 
cortical hem is dependent on LIM-homeodomain factors, in particular Lhx2 and Lhx5; loss of 
Lhx2 expands dramatically the hem and choroid plexus at the expense of the cortex 
44
(Fig.19). 
The commissural plate is an anterior patterning center for arealization placed at the 
rostromedial pole of telencephalon. It is the derivative of the anterior neural ridge (ANR) and 
express Fgfs (8, 15, 17, 18). 
Finally, the antihem (on the lateral side of the cortical field, at the pallial–subpallial boundary), 
express an heterogeneous mix of SLs including Egf-like molecules (TGFα, Nrg1, Nrg3), the Wnt-
chelating protein Secreted frizzled-related protein 2 (Sfrp2) and Fgfs (7, 15),antagonizing Wnt 
signaling coming from the hem
45
. 
 
 
24 
 
 
 
 
 
 
 
1.4.1.Cortical specification: transcription factors. 
 
At the onset of the primary neuronogenesis, a number of transcription factors involved in the 
specification of cortical areas are expressed in proliferative layers of the developing neocortex, 
according to distinct spatial gradients . 
These TFs belong to different families and their gradient can be oriented in different ways.  
Some of them are restricted to the pallial VZ (Emx2, Pax6), some are also detectable in 
subventricular and/or more MZs (Lhx2, Emx1, Foxg1, Couptf1, Sp8). The expression of these 
genes is regulated by patterning edges and the information flow from SLs to TFs takes place 
through a complex functional network(Fig.17). 
 
Figure16. Localization of 
the signaling centers 
involved in cortical 
arealization. 
Abbreviations: Ctx, cortex; 
LGE, lateral ganglionic 
eminence; MGE, medial 
ganglionic eminence;CGE, 
caudal ganglionic eminence; 
OB, olfactory bulb. (Adapted 
from Corbin et al, Nature 
Neuroscience  4, 1177 - 1182 
,2001). 
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1.4.2.Cortical Arealization “Master genes”. 
 
Genetic dissection of genes linked to arealisation showed that a large subset of TFs and 
secreted ligands involved in mastering this process not only impart specific areal identities to 
neuroblast located in distinctive parts of the cortical primordium but also control their kinetic 
behaviour (proliferation, differentiation, apoptosis), so finallyregulating: 
(a) tangential expansion rates of distinct cortical regions 
(b) radial neuronal output of distinct cortical regions 
Among these genes, major roles are played by Foxg1,Pax6, Emx2 and Lhx2. 
Figure 17. Expression patterns of SLs and TFs implicated in cortical arealization. 
 (a) Synopsis of SLs expressed by the three signaling edges of the cortical field. (b) Idealized representation 
of  tangential expression gradients of patterned TFs. Dorsal views. Abbreviations: d, diencephalon; m, 
mesencephalon; t, telencephalon (Adapted from:Mallamaci A:Progress in Brain Research 189: 37-74, 2011). 
. 
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Lhx2 is stimulated by Bmps (2 and 4) at low concentrations and inhibited by the same ligands at 
high concentrations. This may account for the peculiar Lhx2 dorsomedial expression profile: 
absent in the hem, high in archicortex, lower in neo/paleocortex 
56
. 
Foxg1 is inhibited by Bmps (2 and 4, but not 6 and 7) 
43
 and Wnt signaling 
57
, and strongly 
promoted by Fgf8
24
. 
Emx2 is promoted by Bmps and Wnts 
73,74
 as well as inhibited by Fgf8
24,58,59
. 
Pax6 is strongly inhibited by canonical Wnt signaling 
60,61
 and promoted by Fgf8, specifically in 
rostral pallium
24
. 
Lhx2 is a cortical selector gene. Lhx2 selector activity is specifically required by cortical stem 
cells, without which these cells eventually adopt hem or antihem fates rather than hippocampal 
or neocortical identities. 
The absence of neocortex and hippocampus in Lhx2 null embryos contrasts with the 
preservation of one or both of these cortical structures in Pax6, Foxg1, and Emx1/2 null 
mutants (Fig. 18) . These transcription factors are therefore likely to act after Lhx2, with Foxg1 
being a mediator of Lhx2-dependent hem fate suppression . Lhx2 is itself downstream of Six3 in 
zebrafish , which is required to form the entire rostral prosencephalon, suggesting that Six3 
creates a rostral forebrain field within which Lhx2 specifies cortical identity. 
 
 
 
 
 
 
Figure 18. Schematics of mutant dorsal 
telencephalic phenotypes illustrating how the 
complete absence of hippocampus and neocortex is 
unique to the Lhx2 mutant (4,5,28-30). AH, antihem; 
H, hem; Hippo, hippocampus; Ncx, 
neocortex.(Adapted from Vishakha S. Mangale 
et al., Science 319, 304 (2008); DOI: 
10.1126/science.1151695). 
 
 At early ages, both Foxg1 and Lhx2
eventually their expression delineates a sharp boundary between the cortical tissue and the 
hem. Further, in mice mutant in these genes, the cortical hem expands, suggesting their role in 
actively confining the lateral extent of the hem. An important difference between these two 
molecules is that in FoxG1 mutants both the hem and the medial part of the cortical 
neuroepithelium expand (Muzio and Mallamaci 2005); 
cortical hem (as well as the lateral antihem) expands at the expense of the cortex
This suggests a more specific role for the LIM homeodomain transcription factor Lhx2 in 
defining the hem--cortex boundary, whereas FoxG1 probably regulates the broad medial 
telencephalic domain. 
In  the pallium, Gli3 expression will be flanked by the combined expression of the transcription 
factors Pax6 and empty spiracles homeobox 2 (Emx2)
They are expressed early in the dorsal forebrain (E8.5)
and are both necessary for dorsal telencephalon specification: Emx2
expansion of the choroidal roof and the subpallium at the expense of the cortex 
 
 
 
 
 
 
 
Figure 19 | Mutant phenotypes of mice knock
involved in cortical specification. Abbreviations: CH, cortical hem; CR, choroidal roof; ChP, choroid 
plexus; Cx, cortex; Lge, lateral ganglionic eminence; Mge, medial ganglionic eminence; Pcx, 
paleocortex. Adapted from Molyneaux 
 
27 
 are expressed throughout the cortical neuroepithelium and 
in Lhx2 mutants - however 
 (Fig.20 ). 
46,49
 along opposite gradient (see below) 
-/-
 Pax6
-/-
 
-out for the Lxh2 and Foxg1, transcription factor 
et al., Nat Rev Neurosci. 2007. Jun;8(6):427-37. 
- only the 
54,60
(fig. 19). 
 mice exhibit an 
(Fig.20)
63,64,65
. 
  
Figure20.  Emx2 involvement in dorsal forebrain specification.
Loss of both Pax6 and Emx2 results in ventralization of cortical progenitors and the loss of the
(Ncx), archicortex (Acx), cortical hem (CH) and choroid plexus (CPl), choroid
roof) (ChF) by embryonic day 14 (Adapted from Muzio & Mallamac
Rev Neurosci. 2007 Jun;8(6):427-37.
 
 
 
 
Remarkably, in Gli3-/- mice Emx2 is downregulated
phenotype to Emx2
-/-
Pax6
-/-8
, suggesting that Emx2 is downstre
The concerted activity of dorsal forebrain patterning centers and transcription factors 
expressed in the telencephalic field further subdivides the cerebral cortex in distinct anatomical 
and functional areas. 
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 field(choroid plexus and choroidal 
 Cereb Cortex. 2003 Jun;13(6):641
). 
66
 and Gli3
-/-
Pax6
-/-
 mice have a similar 
am to Gli3. 
 
 neocortical domain 
-7 and Nat 
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1.5. Development of the neocortex. 
 
In mice, development of the neocortex begins at embryonic day 9.5 (E9.5) with the appearance 
of the cerebral vesicles from the dorsal surface of the rostral neural tube. 
Initially, the neocortical primordium is comprised of an apparently homogenous pool of neural 
stem cells. The first postmitotic neurons of the neocortex, the Cajal-Retzius cells, appear at 
E10.5-E11.0 to form a transient structure known as the marginal zone that later becomes layer 
1. The Cajal-Retzius cells (CR) secrete Reelin, anextracellular matrix protein that play a 
fundamental role for the formation of cortical layers during embryonic development and their 
maintenance in adulthood
64
. CR neurons arise from restricted locations at the borders of the 
developing pallium, the hem, the antihem and the septum
65,66
, and spread into the cortex by 
tangential migration. The subsequent generation of the glutamatergic projection neurons of 
layers 2–6 by neocortical stem cells takes place from E11 until approximately E17, with neurons 
of deep layers (layer 6) produced before those of the outer layers (2/3) (Fig. 21A).  
Postmitotic layer neurons born in the VZ migrate radially outwards to form the layers VI-II of 
the cortical plate. This migration takes place along the processes of radial glial cells that span 
the width of the developing neocortex (Fig. 21B).Neurons of layer 6 are first to leave the 
ventricular zone and migrate radially to form the nascent cortical plate. Neurons of layer V to II 
then migrate past those of layer VI and adopt successively superficial positions (Fig. 21A). 
The glutamergic neuronal progeny of neocortical stem cells form radial columns that span the 
cortical plate
70,71
(Fig. 21C). By contrast,  inwardly migrating inhibitory GABAergic interneurons 
arriving from the ganglionic eminences of the ventral forebrain migrate by tangential dispersion 
(
72,73,74
).  
This model, known as  ”radial unit hypothesis”, gave rise to the idea that a spatial pattern in 
neocortical stem cells is transferred to the neurons of the cortical plate. 
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1.5.1.Cortical progenitors. 
 
Neural progenitors are initially generated in a proliferative layer adjacent to the lateral 
ventricles called ventricular zone (VZ). The first postmitotic cortical neurons form a transient 
structure called the preplate (PP). The PP persists until embryonic day (E) 13 in mice, when the 
earliest cortical plate cells reach the upper part of the neuroepithelium and divide the PP into 
two regions: the superficial marginal zone (MZ) (future layer 1) and the lower subplate (SP) 
75,76
. 
The cortical plate (CP), which will become the mature six-layered neocortex, is formed between 
these two layers according to an “inside-out” neurogenetic gradient, with later generated 
neurons bypassing early gene rated cells to settle at the top of the cortical plate, forming the 
upper layers of the cerebral cortex. As cortical development proceeds, an additional 
Figure21.Cortical stem cells are multipotent, generating neurons for each layer in a fixed 
temporal order. 
(A) Layer-specific neurons are generated in a fixed temporal order in a classic inside-out 
pattern over 6 days in the mouse cortex. (B) Neurons (blue) and generated by radial glia 
stem cells (green) in the ventricular zone and subsequently migrate radially outwards into 
the cortical plate along the processes of the radial glia cells that span the width of the 
developing neocortex. (C) Cortical stem cells generate radially arranged clones of neurons in 
mice and primates. Examples of retrovirally labeled clones are redrawn from Kornack 
and Rakic Neuron 15:311–321.1995 and Yu et al. 2009. 
 
31 
 
proliferative zone, called subventricular zone (SVZ), appears on top of the VZ. It will initially give 
rise to projection neurons and subsequently to glia
77
(fig.22). 
 Different types of progenitors, characterized by the expression of different genes, contribute to 
cortical neurogenesis. Two principal classes have been identified on the basis  of their nucleus 
position during the M-phase of the mitotic cycle: 
(1) apical progenitors, so called because dividing at the ventricular (apical) surface of the VZ and 
expressing Pax6 gene 
78
. They include neuroepithelial cells (NE)and  radial glia cells (RGCs), 
which contact both the ventricular cavity and the meninges, as well as short neuronal 
precursors (SNPs) (Fig.23a) 
79,80
.Short Neural Precursors (SNP) are similar to RGCs, however, 
they have a basal process which does not reach the MZ, so showing a “pin-like” morphology 
(fig.23). They undergo IKNM similarly to NE and RGC cells, but can be distinguished from other 
apical progenitors by the activity of the alpha 1 tubulin promoter (pTα1)
80,83
. 
 
 
 
 
 
(2) basal or intermediate progenitors (IPC), that undergo division away from the ventricular 
surface, often at the VZ/SVZ border (Fig.23b) 
81,82
 and express the transcription factor Tbr2
78
. 
Figure 22. Mouse cortical neurogenesis. 
Abbreviations: CP, cortical plate; IZ, 
intermediate zone, PP, preplate; MZ, marginal 
zone; SP, subplate; SVZ, subventricular zone; 
VZ, ventricular zone. 
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At early stages, NE cells undergo a symmetrical self-renewing pattern of cellular divisions, so 
leading to an increase of the surface area of the VZ.  Around E10 in mouse, the NE division 
pattern progressively switches to a more asymmetric one, giving rise to the first neurons and to 
Radial Glial Cells (RGCs). RGCs share with NE cells many histological, morphological and 
molecular properties, including full histogenetic potentials, radial morphology and IKNM. At a 
molecular level, both populations express the transcription factor Pax6 and the intermediate 
filament protein Nestin 
84
. 
Remarkably, the basic-helix– loop–helix (bHLH) Hes transcription factors seem to be important 
for the NE-to-RGC transition: mice deficient in Hes1 and Hes5 show normal NE cells at E8 but 
impaired RGC differentiation at E9.5 
85
. Thus, Notch signalling mediated by Hes transcription 
factors seems not to be required by NE cells. 
Basal progenitors, also called Intermediate Progenitor Cells (IPC), originate from apical 
progenitors and   (1-3 mitoses). They show a multipolar morphology and do not undertake 
INKM. Their post-mitotic output forms the vast majority of the glutamatergic neuronal 
complement of the cortex. 
 
1.5.2.Gene expression profiles of cortical progenitor subtypes. 
 
A large number of transcription factors regulate the choice between proliferationand 
differentiation, inhibiting or promoting the exit from the cell cycle. In particular, Emx2and Tlx 
genes favor progenitors proliferation 
86–88
, Pax6 promotes the maintenance of the size of the 
Figure 23.Schematic overview on 
different types of mouse cortical 
precursors. 
Abbreviations: IPCs, intermediate 
progenitor cells; RGCs, radial glia 
cells; SNP, short neural precursors. 
Image modified from Dehay and 
Kennedy, Nat Rev Neurosci 8:438-
50,2007. 
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cortical progenitor pool
89
. Proneural genes (Ngn1 and Ngn2) promote neuronal 
fatecommitment, whereas members of the Hes and Id families are important inhibitors 
ofneuronogenesis. RGCs cells are maintained in the proliferative state by the simultaneously 
action of different genes (such as Emx2, Hes1, Hes5, Id3, Id4) (Fig. 24). The direct transition 
from radial glia to newborn neurons is regulated by Ngn1 and Hes5 genes and correlate with 
downregulation of radial glia marker Pax6 and upregulation of postmitotic neuronal markers 
Tbr1, Math2, and neuroD2 
78,90,91
.  
In the case of indirect neurogenesis, the transition from radial glia to basal progenitors involves 
upregulation of Tbr2 and downregulation of Pax6
78
 (Fig.25). The subsequent transition from 
IPCs to neurons correlated withdownregulation of Tbr2 and upregulation of Tbr1, Math2, and 
NeuroD2, NeuroD (whichare all expressed by newborn cortical  
 
 
 
Figure 24. Model for TF regulation of direct and indirect pathways of cortical neurogenesis.(Adapted  from 
HevnerMol Neurobiol 2006;33:33-50). 
 
 
projection neurons, at least transiently). So, the TF sequence Pax6→Tbr2→Tbr1 characterizes 
the transition RGC→IPC→postmitotic neuron 78. 
34 
 
In Pax6 -/-, radial glial progenitors present defects in their mitotic cycle, molecular phenotype 
and morphology
92
. Moreover, a loss of Tbr2+ cells corresponding to basal progenitors can be 
identified, indicating that Pax6 is necessary for the activation of Tbr2 expression 
89
. The 
expression of Pax6 protein in cortical progenitors determines also the expression of the 
proneural gene Ngn2, providing evidence of a direct regulatory link between neural patterning 
and neurogenesis 
93
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 25. Transcription factors 
implicated in regulating IPC 
production from radial glia. A 
balance of TFs promotes (Ngn2, 
Pax6 and Tlx) or inhibits (Hes1, Id4) 
IPCs production from radial 
glia. (Image taken from Hevener, 
Mol Neurobiol 2006;33:33-50). 
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CHAPTER 2. INTRODUCTION: REPROGRAMMING AND TRANSDIFFERENTIANTION 
IN REGENERATIVE MEDICINE. 
 
A major health challenge is posed by diseases involving postmitotic tissues, whose cells have 
very low or no proliferative capacity. 
The aim of regenerative medicine is to regenerate tissues with no initial capacity for 
regeneration, and there has been increasing scientific interest in the use of cellular therapy for 
this purpose(Fig.26). 
Cell-differentiation and specialization were originally thought to be unidirectional and 
spontaneous reprogramming was rarely observed.  
 
 
 
 
 
Nuclear-transfer studies have shown that adult cells can be reprogrammed into embryonic 
state through transfer of nuclear content from somatic cells into viable oocytes or via fusion of 
somatic cells with ES cells. However, these techniques still require the use of embryos,implying 
major ethical and immune rejection problems. 
 
Figure 26.  The steps of regenerative medicine. 
Setting up cellular therapies requires the 
optimization of four steps: first, isolating and 
culturing cells that can be easily get from a 
patient. Second, the reprogramming of these 
cells into a pluripotent state. Third, the 
differentiation of those patient-specific 
pluripotent cells into the cell type relevant to 
their disease. Fourth,  transplantation of the 
repaired, differentiated cells into the patient. 
Remarcably, disease-relevant patient cells can 
also be used for in vitro disease modeling which 
may be a powerful tool for disease mechanisms 
understanding and drug discovery. 
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Two main approaches has been developed to overcome these issues(fig 27): 
1)  the generation of  induced pluripotent stem cells (IPs), derived directly from the 
patient’s own somatic cells, having the capacity to replace tissue and, thus, avoiding 
allotransplantation problems. This approach has a great clinical potential, however 
employment of iPS cells in therapy is presently limited by the not negligible risk of 
tumor formation. 
 
 
 
 
 
 
 
 
 
 
2) the so-called transdifferentiation process , by which differentiated cells can change fate 
and become another differentiated cell type. This approach should provide the large 
numbers of cells required for transplantation.  
Figure 27. Main strategies cell fate change.It is possible to achieve de-differentiation or induced pluripotency 
by the ectopic expression of four transcription factors (Oct4,Sox2,klf4,c-Myc; Takahashi and Yamanaka,2006) in 
fibroblasts or just one(Oct4) in neurons. The direct transdifferentiation from fibroblasts (mesoderm) to 
functionalinduced neurons (iN) cells (ectoderm) require the ectopic expression of three transcription factors 
:Ascl1,Brn2,Mytl1 (Vierbuchen et al.,2010). The reversal conversion has not been described yet (Adapted from 
Masip et al., Molecular Human Reproduction, Vol.16, No.11 pp. 856–868, 2010). 
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3) However, considerable work is still needed to develop a definitive method for the long-
lasting differentiation of cell types with therapeutic value. 
 
 
2.1. Generation of pluripotent stem cells. 
 
Research on embryonic stem (ES) cells  has started since 1980s. ESC are derived from the inner 
cell mass of mammalian blastocysts and are characterized by peculiar features, such as the 
ability to grow indefinitely while maintaining pluripotency and the ability to differentiate into 
cells of all three germ layers 
94,95
. Human ES cells might be used to treat a huge number of 
diseases, such as Parkinson’s disease, spinal cord injury, and diabetes 
96
. However, ethical 
difficulties regarding the use of human embryos, as well as the problem of tissue rejection 
following transplantation in patients have been hampering the research progress. 
There are several ways to circumvent these issues. One is the employnment of somatic (adult) 
stem cells (ASCs) as a source of pluripotent cells. Unfortunately, this strategy has many 
limitations, in particular: 
(i) ASCs are relatively rare undifferentiated cells found in many organs and differentiated 
tissues, 
(ii) their isolation into pure populations is not always possible  
(iii) they have a limited capacity for both self-renewal (in vitro) and differentiation since 
these cells  are notpluripotent but multipotent (their differentiative potencial is strongly linked 
to the tissue from which they originated ) 
(iv) moreover, anisogenic ASCs can cause rejection after allotransplantation. 
 
For these reasons, in the last years researchers focused on the generation of induced 
pluripotent cells derived directly from the patients’ own cells. 
Somatic cells can be reprogrammed by three main strategies(fig.28): 
a) exposure to oocyte-specific factors through somatic cell nuclear transfer (SCNT) 
b) exposure to factors expressed in pluripotent cells (i.e. embryonic stem cells) through cell 
fusion  
38 
 
c) overexpression of defined transcription factors involved in manteining pluripotency in 
ES cells(direct reprogramming)
97
. 
 
 
 
 
 
 
 
 
 
 
a) Somatic cell nuclear transfer (SCNT). 
It has been described in 1997 byWilmut et al.
98
, who showed that adult somatic cells 
could be reprogrammed back into an undifferentiated embryonic state  by transferring 
diploid donor nuclei into enucleated MII oocytes that are activated on, or after transfer. 
The reconstructed embryos are then cultured and selectedembryos transferred to 
surrogate recipients for development to term.Unfortunately, since then, attempts to 
generate patient-specific cells using SCNT have proven unsuccessful 
99–101
. 
 
 
Figure 28.  Strategies of nuclear reprogramming: advantages and limitations. 
There are three main  techniques for restoring developmental potential to a somatic nucleus. The nuclear 
transfer, by which the genetic material of an oocyte or zygote is replaced with that of a differentiated cell.   
The  cellular fusion is an hybridization between ES cells and somatic cells, generating tetraploid ES cell 
lines. The direct reprogramming bases on the retroviral mediated introduction of a small group of 
transcription factors able to induce a pluripotent state (Adapted from stem book). 
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b) Cell fusion. 
There are many examples in literature showing that a pluripotent phenotype arise 
following the fusion of murine somatic cells to EC 
102
, embryonic germ 
103
, and ES
104,105
 
cells. These studies seemed to promise that somatic-stem cell fusion might be an 
appealing alternative to inefficient and challenging NT. 
It was hoped that this system could be used for either the study of the mechanisms of nuclear 
reprogramming or ,possibly, the direct production of patient-specific pluripotent stem cells. In 
2005 Cowan et al
106
. demonstrated that this capacity to reprogram somatic cells is conserved in 
human, as well as in mouse. 
Cowan et al. fused hES cells with human BJ fibroblasts (Fig. 29) and assayed the ability of hybrid 
cells to differentiate in vitro and in vivo. They  found that : 
- when cultured in suspension, hybrid cell lines formed embryoid bodies (EBs), 
-  after injection into nude mice , they formed teratomas, 
- both a teratoma (Fig. 30, C to E) and EBs (not shown) contained cells expressing βIII-
tubulin (neurectoderm) muscle-specific myosin (mesoderm) and alpha-fetoprotein 
(endoderm).  
 
 
 
 
Figure 29.Fusion of hES cells and human somatic cells. Somatic and hES cell lines were stably transduced or 
transfected with independent drug-resistant markers . In a second step, they  were treated with PEG to induce 
cellfusion. The selection of cell hybrids was achieved by  growing fused cells in standard culture medium of hES 
cells inthe presence of antibiotics (Adapted from Chad A. Cowan,Science 309, 1369 ,2005). 
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Hybrid cells also expressed the embryonic gene Rex-1, encoding for a retinoic acid–regulated 
zinc-finger protein expressed in ES cells (not shown). 
 
 
 
c) Direct reprogramming. 
Despite the initial xcitement, the fusion of ES and somatic cells, as well as the 
subsequent reprogramming, resulted  to be quite inefficient 
105–107
, limiting  usefulness 
of this approach to  the study of the genetics and epigenetics of reprogramming. 
Moreover, the presence of two complete genomes  put severe limits to the utility of this 
methodology for the study of reprogramming and represented an enormous technical 
barrier to the production of autologous stem cells. 
However, these works strongly suggested that unfertilized eggs and ES cells contain factors that 
are sufficient to confer totipotency or pluripotency to somatic cells. 
This awareness has inspired the subsequent development of the third strategy, the direct 
reprogramming. 
 Figure30. Hybrid cells phenotype. 
(A)Drug-resistent hybrid cells shown a HES cells –like 
morphology (B) Both HES cells and hybrid cells 
expressed the GFP (green) and the transcription 
factor OCT4 (red), whereas the GFP-negative BJ 
fibroblasts cells were negative for Oct4. (C) Hybrid 
cells-derived teratomas showed various cell types, 
including neurons  expressing a neural-specific 
tubulin (Tuj1, red) (D), skeletal muscle expressing 
myosin heavy chain (MF20, red)and (E)alpha-
fetoprotein(AFP,red) (Adapted from Chad A. 
Cowan,Science 309, 1369 ,2005). 
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This brilliant approach was described for the first time in 2006, byYamanaka and 
Takahashi
97
.They reported that mouse embryonic fibroblasts (MEFs) and adult tail tip 
fibroblasts could be reprogrammed back to a pluripotent state by introducing four transcription 
factors (Oct3/4, Klf4, Sox2, and c-Myc) via retroviral delivery, coupled to reactivation of 
endogenous loci of genes that are essential to pluripotency: Oct4 and Nanog.  
They termed these cells “induced pluripotent stem” (iPS) cells
97
.Detailed characterization 
revealed that iPS cells share many features with ESCs (fig.33-34-35), such as morphology, 
marker genes expression, immortal proliferation  and  pluripotency, as defined by their ability 
to generate teratomas and differentiate into all the lineages of the three germ layers, including 
germ cells that can ultimately give rise to offspring 
97,108–110
.  
In a first step of their study, Yamanaka et al.selected and introduced 24 candidate genes 
intomouse embryonic fibroblasts (MEFs)(Box1) and generated, in this way,  22 Fbx15 expressing 
colonies (Fig.31B), where Fbx15 is a marker specifically expressed in mouse ES cells and early 
embryos. About an half of these clones exhibited morphology similar to ES cells, including a 
round shape, large nucleoli, and scant cytoplasm (Fig.31C). 
 
 
 
 
 
Fig.31. Generation of iPS Cells from MEF Cultures via 24 Factors(A) Experimental Strategy (B) G418-
resistant colonies resulting from the transduction with a combination of 24 factors. Cells were stained 
with crystal violet 16 days after infection. (C) Morphology of ES cells, iPS cells and MEFs. Scale bars = 200 
mm. (Adapted from Takahashi and  Yamanaka, volume 126, Issue 4, 25 August 2006, Pages 663–676). 
 Next, by removing individual factors from the 
4, 5, 11, 14, 15, 18, 20, 21, and 22) whose individual withdrawal from the bulk transduction 
pool resulted in no colony formation
after transduction.Interestingly, transduction of MEFs with the pool of these 10 factors resulted 
in increased frequency of colony formation, compared to the origi
Yamanaka et al.  also evaluated the formation of colonies after withdrawal of individual factors 
from the 10-factor pool transduced into MEFs 
did not form when either Oct3/4 (factor 14) or Klf4 (factor 20) w
(factor 15) resulted in only a few Fbx 15 expressing colonies.   After c
22), Fbx 15 expressing colonies were more numerous, bu
morphology. 
 
Figure32. Identification of the 4-factors
August 2006, Pages 663–676). 
 
These results allowed to identifyOct3/4, 
generation of iPS cells from MEFs.
- Oct3/4 and Sox2 were essential for the generation of iPS cell
42 
24 genes pool , they could identify 
, 10 days after transduction, and fewer colonies 16 days 
nal 24 genes pool.
(Fig.32B).Remarkably, Fbx 15 expressing
ere  removed. 
-Myc withdrawal  (factor 
t they had a flatter, non
 
-pool(Adapted from Takahashi and  Yamanaka, volume 126, Issue 4, 25 
Klf4, Sox2, and c-Myc  as “main players” in the 
  In particular, they found that : 
s 
10 factors (3, 
 
 colonies 
Removal of Sox2 
-ES-cell-like 
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- Nanog was dispensable 
- the two tumor-related factors c-Myc and Klf4 were essential factors and could not be 
replaced by other oncogenes including E-Ras, Tcl1, b-catenin, and Stat3 (Fig.32A and 32B). 
RT-PCR analysis revealed that, iPSMEF10 and iPS-MEF4 clones expressed the majority of ES 
marker genes, with the exception of Ecat1(fig.33). 
 
 
 
 
Moreover, the promoters of Oct3/4 and Nanog showed  an increased  acetylation of histone H3 
and decreaseddimethylation of lysine 9 of histone H3 (Fig.33B).  
From the global gene expression point of view,  iPS cells were  clustered closely with ES cells but 
separately from fibroblasts and their derivatives (Fig.34A). In particular, iPS-MEF4 and 
iPSMEF10 cells expressed  alkaline phosphatase and SSEA-1 (Fig. 33D). 
 
Figure 33. Gene-Expression 
Profiles of iPS Cells. 
(A) RT-PCR profiling of IPS-
MEFs3-4-10. (B)  Chromatin 
immunoprecipitation 
analyses.  
(C) CpG dinucleotides in 
these promoters remained 
partially methylated in iPS 
cells. (D) Immunostaining for 
alkaline phosphatase and 
SSEA-1 (Adapted from 
Takahashi and  Yamanaka, 
volume 126, Issue 4, 25 
August 2006, Pages 663–
676). 
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The iPS cells pluripotency was also analysed by teratoma  formation (Fig.35).  Histological 
examination revealed that  the majority ofiPS-MEF10 and iPS-MEF4 clones exhibited 
pluripotency (meant as the capability to differentiate into all three germ layers, fig. 35D). 
Hence, iPS-MEF4 and iPS-MEF10 cells were similar, but not identical, to ES cells. 
Figure 34. Pearson correlation analysis of  the 
global gene-expression profiles in ES cells, iPS 
cells, and Fbx15bgeo/bgeo MEFs by DNA 
microarrays(Adapted from Takahashi and  
Yamanaka, volume 126, Issue 4, 25 August 2006, 
Pages 663–676). 
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Figure 35.  Pluripotency evaluation of iPS-
MEF10 and iPS-MEF4 clones. 
(A)Tissues present in teratomas derived 
from iPS-MEF4-7 cells. When grown in tissue 
culture dishes, the embryoid bodies from iPS-
MEF10 and iPS-MEF4 cells attach to the dish 
bottom and initiate 
differentiation(B)Ddifferentiation 
into neural tissues and muscles in teratomas 
derived from iPS-MEF4-7.(C) Embryoid bodies 
from iPS-MEF3 cells remained 
undifferentiated even when cultured in 
gelatin-coated dishes These data confirmed 
pluripotency of iPS-MEF10 and iPS-MEF4 and 
nullipotency of iPS-MEF3 in vitro. 
(D)  Immunostaining for germ layers markers. 
fter 3 days, immunostaining detected cells 
positive for a-smooth muscle actin 
(mesoderm marker), a-fetoprotein (endoderm 
marker), and bIII tubulin (ectoderm 
marker)(Adapted from Takahashi and  
Yamanaka, volume 126, Issue 4, 25 August 
2006, Pages 663–676). 
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2.2. Induced pluripotency by defined factors in human somatic cells. 
 
iPS cells can be generated also from adult Human Dermal Fibroblasts (HDFs) and other somatic 
cells(i.e.  IMR90 fetal fibroblast line
111
, as well as post-natal fibroblasts
112
) by retroviral 
transductionof two different cocktails of factors: 
-the so-called “Yamanaka factors”, Oct3/4, Sox2, Klf4, and c-Myc
112
 
- OCT4, SOX2,NANOG, and LIN28
111
. 
So-generated human iPSCsfrom adult HDFs and other somatic cells are similar to hES cells for 
what concerns morphology, proliferation, feederdependence, surface markers, gene 
expression, promoteractivities, telomerase activities, in vitro differentiation,and teratoma 
formation(fig.36-37)
112
.  
Box1. Fibroblast employnment in reprogramming  experiments. So far, fibroblasts have been 
the main substrate for cell fate reprogramming to generate neurons, but  other cell types, 
including somatic cells such as hepatocytes as well as germ cells, have been successfully 
reprogrammed into functional iNs, demonstrating that interlineage transdifferentiation is 
possible (Marro S et al., 2011; Tursun B et al., 2011). Nevertheless, fibroblasts remain the 
preferred cell type due to their relative availability. Infact, since fibroblasts can be easily obtained 
from patients through minimally invasive methods, the generation of patient-specific cells is 
relatively simple. 
Another  important factor that must be considered in cell fate reprogramming is the origin of the 
cell lineages. Fibroblasts differentiate from mesenchymal progenitor cells, some of which are 
derived from neural crest lineages. Neural crest cells originate in the ectoderm on the dorsal tip of 
the early embryonic neural tube. From there, they progress through an epithelial–mesenchymal 
transition and pervasive migration, ultimately differentiating into an array of tissues throughout 
the body. Consequently, fibroblasts share a neuro-ectodermal lineage with neuronal cells, unlike, 
for example, hepatocytes, which are derived from the endoderm. Moreover, fibroblast cultures are 
likely heterogeneous in cell types and often contain neural crest-derived stem cells (Bayreuther K 
et al., 1988).  These cultures may contain multipotent stem cells with the capacity to differentiate 
into neurons, due in part to their shared lineage. Therefore, easy access and lineage features make 
fibroblasts the favorite cell type for reprogramming to neurons. 
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Remarkably, Oct3/4, Sox2, Klf4, and c-Myc expressing retroviruses arestrongly silenced in 
human iPS cells, indicating that the new pluripotent state acquired by theseelements do not 
depend oncontinuous expression of the transgenes for self renewal
112
. 
Remarkably, fibroblasts are not the only kind of somatic cell which may be reprogrammed. In 
humans, many different cell types have been reprogrammed, including keratinocytes 
113,114
, 
CD34+ hematopoietic stem cells 
115
, cord blood-derived CD133+ stem cells 
116
, cord blood-
derived endothelial cells 
117
, melanocytes 
118
, neural stem cells  
 
 
 
 
 
 
Figure 36. Teratoma 
Derived from Human iPS 
Cells. 
hIPs were transplanted 
subcutaneously  into four 
parts of a SCID mouse. The 
teratoma derived from iPS 
cells was stained for 
hematoxylin and eosin 
(adapted from Takahashi, K. 
et al., 2007; Volume 131, 
Issue 5, 30 November 2007, 
Pages 861–872.  
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(NSCs)
119
, amniotic fluid-derived cells 
120
, CD34+ peripheral blood cells from patients with 
myeloproliferative disorders 
121
, adult human adipose stem cells from lipoaspirate 
122
, human 
mesenchymal-like stem/progenitor cells of dental tissue origin
123
 and mesenchymal stem cells 
from umbilical cord matrix and amniotic membrane
124
.   
The original work of Takahashi and Yamanaka in 2006  demonstrated the possibility of 
generating iPS cell colonies by the co-transduction of Oct3/4, Sox2, Klf4 and c-Myc. Apparently, 
Figure 37. iPS Cells from Adult 
HDF. 
 
(A) iPS cell generation protocol. 
(B) Morphology of HDF. 
(C) Example of non-ES cell-like 
colony. 
(D) hES cell-like colony. 
(E) Typical morphology of  iPS cell 
line at 
passage number 6. 
(F) Image of iPS cells with high 
magnification. 
(G) Spontaneously differentiated 
cells in the center part of human 
iPS cell colonies. 
(H–N) Immunoprofiling for SSEA-1 
(H), SSEA-3 (I), SSEA-4 (J), TRA-1-60 
(K), TRA-1- 81 (L), TRA-2-49/6E (M), 
and Nanog (N). Nuclei were 
stained with Hoechst 33342 (blue). 
Bars = 200 mm (B–E, G), 20 mm (F), 
and 100 mm (H–N). 
(adapted from Takahashi, K. et al., 
2007, Volume 131, Issue 5, 30 
November 2007, Pages 861–872) 
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the most important factor is Oct3/4, since its expression is highly specific for pluripotent stem 
cells and cannot be replaced by other members of the Oct family
125
. 
Moreover,the ectopic expression of Oct3/4 alone is sufficient to generate iPS cells from human 
NSCs derived from human fetal brain tissue (Fig. 38)
126
.  
 
 
 
 
Clones from one-factor iPS cell colonies are able to generate teratomas and adult chimeric 
mice. 
These studies revealed the importance of Oct4 in inducing pluripotency in NSCs, although it 
must be emphasized that these cells endogenously express the rest of the Yamanaka factors, as 
well as several intermediate reprogramming markers, which possibly facilitates reprogramming 
in the absence of exogenous addition of these factors. 
 
 
- Generation of iPS by alternative combination of factors 
It has been subsequently shown that, in addition to the original "Yamanaka cocktail ", it is 
possible to generate iPS cells by retroviral transduction of several other factors 
combinations. Among them : 
- Oct4 and Sox2 with Lin28 and Nanog 
117,127
,  
- Oct4 together with either Klf4 or c-Myc 
128
,  
- Oct4, Sox2, Nanog 
129
 
- Oct4 and Sox2 
116,130,131
,  
Figure 38. 1F human NSC-
derived iPS cell colony. 
Analysis of pluripotency and 
surface markers (OCT4, 
SSEA4, TRA-1-60 and TRA-1-
81) in 1F  human NiPS cells. 
Nuclei are stained with DAPI 
(blue). Scalebars, 250 mm. 
(Adapted from Kim et 
al.,2009; Vol 461| 1 October 
2009| 
doi:10.1038/nature08436). 
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- Oct4 and Klf4
132
, 
-  Sox2, c-Myc and Tcl-1A 
133
. 
Moreover, it has been studied if and how each of the four "Yamanaka genes" may be 
eliminated or replaced. Sox2has been reported to be dispensable for reprogramming neural 
progenitor cells (Eminli et al., 2008), and also melanocytes and melanoma cells 
118
. 
Klf4 can be replaced with Esrrb, an orphan nuclear receptor, in reprogramming mouse 
embryonic fibroblasts (MEFs) 
134
. Interestingly, it has been shown impossible to replace Oct4 
with its closely related family members Oct1 and Oct6 
125
 to date. However a recent report 
describes how the nuclear receptor Nr5a2 can replace exogenous Oct4 in the reprogramming of 
murine somatic cells to iPS cells
135
.  
In summary, these studies reveal that the differences needed in the cocktail of factors for 
reprogramming specific cell types are directly related to the endogenous levels of these factors 
in the target cell(s). 
 
2.3. Clinical employment of iPS cells: limitations and possible solutions. 
 
The progress from mouse to human iPSCs has opened the possibility of autologous regenerative 
medicine whereby patient-specific pluripotent cells could be derived from adult somatic cells. 
However, several limitations of most existing iPSCs prohibittheir usage in the clinical setting 
136
: 
- virus-mediated delivery of reprogramming factors introduces unacceptable risks of 
permanent transgene integration into the genome. The resulting genomic alteration 
(insertional mutagenesis) and possible reactivation of viral transgenes pose serious 
clinical concerns.  
- reprogramming factors Klf4 and c-Myc are oncogenic. 
- iPSC reprogramming is an inefficient and slow process. 
For these reasons, several alternative strategies have been developed, as reported in the next 
paragraph. 
 
 
 2.3.1. Generation of Induced Pluripotent Stem Cells Without Viral Integration
 
Mouse and human iPS cells possess morphological, molecular and developmental features that 
closely resemble those of blastocyst
A major limitation of this technology is the use of potentially harmful genome
viruses. A common strategy for avoiding genomic insertion has been to use a different vector 
for input: plasmids, adenoviruses, and
In 2008, it was demonstrated that it is possible to derive mouse induced pluripotent stem (iPS) 
cells from fibroblasts and liver cells by using non integrating adenoviruses transiently 
expressing Oct4, Sox2, Klf4, and c
plasmids(Fig. 39), one containing the complementary DNAs (cDNAs) of Oct3/4, Sox2, and Klf
and the other containing the c-Myc cDNA, into mouse embryonic fibroblasts
However, the frequency of reprogramming achieved by this approach is extremely low and a 
high percentage of clones are tetraploid.
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.
-derived ES cells.  
 transposon vectors have all been explored.
-Myc or by  repeated transfection of two expression 
137
.
 
 
Figure 39. Generation of virus-free iPS cells. 
(A) Expression plasmids for iPS cell generation. 
The three cDNAs encoding Oct3/4, Klf4, and 
Sox2 were connected in this order with the 2A 
peptide and inserted into the pCX plasmid (pCX
OKS-2A). In addition, the c-
inserted into pCX (pCX
expression. Total RNAs isolated from ES cells, 
retrovirus-induced iPS cells (clone 20D
plasmidinduced iPS cells (clones 440A
8, -10, and -11 and clone 432A
were analyzed with RT-PCR (C) Colonies of virus
free iPS cells. Scale bar, 200 mm.(Adapted from 
Okita et al., 2008,322 (5903): 949
 
 
-integrating 
 
4 
 
 
-
Myc cDNA was 
-cMyc).(B)Gene 
-17), 
-3, -4, -7, -
-1), and MEFs 
-
-953 ). 
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2.3.2. Enhancing Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells. 
  
In general, the efficiency of the iPS cells generationprocess is poor when any of the approaches 
described above are used 
125,138–140
.  
In order to improve the efficiency of inducing pluripotency and to avoid safety issues related to 
viral transduction and genomic integration, it would be ideal to reprogram somatic cells by a 
radically different approach, i.e. by treating them with small molecules, able to trigger the 
activation of gene circuitries which sustain the ES/iPS cell state. 
Several chemicals have recently been reported to either enhance reprogramming efficiencies or 
substitute for specific reprogramming factors (fig.40). In particular, it is possible distinguish two 
main classes of reprogramming drugs: 
- molecules  affecting chromatin modifications 
- molecules influencing signal transduction pathways(table 1). 
 
 
 
 
- Chromatine remodelling drugs 
The covalent modification of nucleosomal DNA and core histones, and ATP-dependent 
chromatin remodelling, are important in the regulation of gene expression, DNA replication and 
many other biological processes. A huge number of proteins that carry out these modifications 
and chromatin remodelling has been identified. 
Figure 40. Reprograming somatic cells 
by treatment with small molecules. 
Molecules such as self-renewal 
modulators (e.g., LIF, MEK inhibitor, 
and GSK3 inhibitor), pluripotency gene 
activators and reprogramming 
boosters may be combinatorially used 
to induce efficient reprogramming. 
Reprogramming boosters : epigenetic 
modulators such as VPA or AZA that 
exert global activation or remove 
repressive chromatin mark, 
respectively (Adapted from Feng et 
al.,Nature Cell Biology 11, 197 – 
203,2009).  
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In ESCs, the Yamanaka transcription factors were found to coregulate the expression of 
epigenetic factors that participate in the maintenance of self-renewal and pluripotency. 
Oct4 and Sox2 co-bind to a group of genes that encode epigenetic factors impacting the 
covalent state of chromatin, such as Smarcad1, Myst3, Jmjd1a, and Jmjd2c
141,142
. Moreover, 
several findings imply that chromatine remodelling represents a major  barrier preventing the 
complete reprogramming to iPS cells97,143. 
These general chromatin-modification and chromatin-remodelling proteins do not act alone, 
but interact with one another, often by forming large protein complexes that regulate higher-
order chromatin structures and the accessibility of chromatin to various factors.  
The stable inheritance of chromatin structure and changes to its accessibility are likely to be 
essential for all chromatin-associated biological processes. 
DNA methylation and histone modification serve as epigenetic marks for active or inactive 
chromatin, and such epigenetic marks are heritable. In mammaliancells,DNA methylation 
occurs predominantly at CpG dinucleotides and is catalysed by two important classes of DNA 
methyltransferases.DNA methyltransferase 1 (Dnmt1) is amaintenance enzyme that methylates 
hemi-methylated CpG dinucleotides in the nascent strand of DNA after DNA replication
144
, and 
its function is essential for maintaining DNA-methylation patterns in proliferating cells
145
. 
Dnmt3a and Dnmt3b are required for the initiation of de novo methylation in vivo and for 
establishing new DNA-methylation patterns during development
146–148
. Both Dnmt1 and 
Dnmt3a have been shown to interact with histone deacetylases (HDACs) and can repress 
transcription149. 
There are evidences showing that DNA methylation is an important epigenetic barrier that 
partially reprogrammed cells may encounter and fail to overcome
150
. 
The isolation of partially reprogrammed stable cell lines, which morphologically resembled 
mouse ESCs but displayed certain transcriptional and epigenetic differences from ESCs, 
supports this notion 
97,143
.  Despite the expression of several ESC-related genes such as Fbx15, 
Fgf4, and Zic3, chimeras could not be derived from such cell lines. Endogenous pluripotency 
genes such as Oct4 and Nanog were not fully reactivated as their respective promoters retained 
DNA methylation. 
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Recently, several reprogramming studies described how small molecules involved in epigenetic 
processes, such as AZA, VPA, and BIX can improve reprogramming efficiencyif combined 
with conventional reprogramming factors. 
151,152
 
 
Treatment with theDNMT inhibitor 5-aza-cytidine (AZA) induces partially reprogrammed 
cells to transit the reprogramming path and form iPSCs
153
. The iPSCs derived with AZA 
treatment reactivated endogenous Oct4, exhibited demethylation at the promoters of 
pluripotency genes, achieved viralsilencing, and formed teratomas when injected into severe 
combined immunodeficiency (SCID) mice.AZA also improved the number of ESC-like colonies by 
4-fold 
150
. 
 
 
 
Table 1. Examples of small 
molecules able to 
enhance the 
reprogramming  process 
or to replace core 
reprogramming factors.O, 
Oct4; S, Sox2; K, Klf4; M, c-
Myc. (Adapted from Feng 
et al.,Nature Cell Biology 
11, 197 – 203,2009).  
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Besides AZA, many other chemical inhibitors have been tested for their capability of 
promote the reprogramming. Among them, several  histone deacetylase (HDAC) inhibitors such 
as valproic acid (VPA), trichostatin A (TSA), and suberoylanilide hydroxamic acid (SAHA) 
significantly enhanced reprogramming efficiencies 
130
.  
Remarcably, Huangfu et al. demonstrated that by treating cells with valproic acidfor a week it is 
possible to improve the percentage of Oct4-GFP-positive cells by more than 100-fold and 50-
fold in case of for three-factor (OSK) and four-factor (OSKM) reprogramming, respectively
154
.  
 
 
Figure 41.AZA and VPA promotefully  induced pluripotency and accelerate thereprogramming kinetics (Adapted 
from Feng et al.,Nature Cell Biology 11, 197 – 203,2009).  
). 
 
 
In addition, combined AZA and VPA treatment induced Oct4-GFP-positive colonies 2 daysearlier 
than nontreated controls 
130
. Hence,HDAC-inhibitors treatment could be useful to improve both 
the kinetics and efficiency of reprogramming. 
Another important molecule is a well established inhibitor of G9a histone 
methyltransferase, named BIX-01294 (BIX). This drug was found to improve reprogramming 
efficiencies of OK-infected NPCs by approximately 8 fold 
152
(see fig. 42). 
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Figure 42. (Image taken from Shi et al. Cell Stem Cell3, 568–574,2008). 
 
 
G9a inhibition by BIX could facilitate the reactivation of Oct4 
155
and promote reprogramming, 
bypassing the need forexogenous Oct4 in SKM-infected NPCs.
152
.Besides Oct4, recently several 
early embryonic genes that are inactivated by G9a have been identified (i.e. Nanog and 
Dnmt3l)
156
. This suggests that BIX, by inhibiting these repressive activities of G9a, could 
derepress pluripotency genes and induce passive demethylation and relaxation of chromatin. 
 
 
 
- Signalling pathway modulation 
Reprogramming induce drastic molecular changes that involve both the upregulation of 
pluripotency genes and repression of differentiation genes. By blocking routes to 
differentiation, one may be able to more effectively direct transduced cells back along the 
desired path toward pluripotency. 
TGFβpathway inhibition.The transforming growth factor beta (TGFβ) signaling 
pathway is involved in many cellular processes in both the adult organism and the 
developing embryo including cell growth, cell differentiation, apoptosis, cellular homeostasis 
and other cellular functions(fig. 43). TGFβ is a prototypical cytokine for induction of epithelial to 
mesenchymal transition and maintenance of the mesenchymal state
157
. 
A major end point of this signaling, in this context, seems to be downregulation of E-cadherin 
158
, an important factor for the maintenance of pluripotency of embryonic stem cells, recently 
suggested to be a regulator of NANOG expression 
159
. 
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In a  recent study, it was shown that administration of the Alk5 inhibitor during expression of 
four reprogramming factors Oct4, Sox2, c-Myc, and Klf4, elicited a striking increase in the 
 
 
 
 
Figure 43.Tgfβ  pathway. (Adapted from Nature Reviews/Molecular biology). 
 
 
 
 
number of iPSC colonies 
160
(Fig.44A). Moreover Tgfβ signaling inhibition enabled faster  iPSC 
induction( fig.44B) and allowed to bypass the  requirement for exogenous cMyc or Sox2(fig.44  
C-D). 
 
 
 
 
 
 Figure44.Tgfβ Signal Inhibition Cooperates in the Induction of 
fromN. Maherali and K. Hochedlinger, Curr. Biol.
 
 
  Wnt signaling activation.
regulates cell fate decisions during development of vertebrates 
The stimulation of the Wnt canonical pathway can 
Oct4, Sox2 and Klf4 in order to increase somatic cells reprogrammingto an induced pluripotent 
state 
161
(see fig. 46). This is probably due to the fact that Tcf3, one of the key transcriptional 
regulators downstream of the Wnt pathway in embryonic stem cells,  co
promoter regions occupied by ESC
can regulate the expression of key ESC transcription factors 
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iPSCs and Replaces Sox2 and cMyc
19, 1718–1723, 2009 ). 
The Wnt/β-Catenin pathway (Wnt canonical pathway) 
and invertebrates
be used in combination with nuclear factors 
-occupies almost all 
-specific transcription factors, including Oct4 and Nanog, 
162–164
. 
 (Adapted 
(fig.45). 
and 
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Figure46. Wnt Signaling Promotes 
Reprogramming of Somatic Cells to 
Pluripotency. (A) Soluble Wnt3a promotes the 
generation of iPS cells in the absence of c
retrovirus (substrate:MEFs carrying a G418 
resistance cassette downstream of the Oct4 
promoter). ICG-001: inhibitor of the Wnt/b
catenin pathway strongly inhibite the effect o
Wnt3a-CM on Myc- iPS formation. (B)The Wnt 
signaling pathway has been shown to connect 
directly to the core transcriptional regulatory 
circuitry of ESCs, suggesting a mechanism by 
which this pathway could directly promote the 
induction of pluripotency in the absence of c
Myc transduction (Adapted from 
al., Cell Stem Cell3, 132–135 ,2008
 
Figure 45. Wnt canonical pathway.
Wnt-ligand is a secreted glycoprotein that 
binds to Frizzled receptors, which triggers a 
cascade resulting in displacement of the 
multifunctional kinase GSK
APC/Axin/GSK-3β-complex. In the absence 
of Wnt-signal (Off-state), β
integral cell-cell adhesion adaptor protein as 
well as transcriptional co
targeted for degradation by the 
APC/Axin/GSK-3β-complex. Appropriate 
phosphorylation of β
coordinated action of CK1 and GSK
to its ubiquitination and
degradation through the β
complex. In the presence of Wnt binding 
(On-state), Dishevelled (Dvl) is activated by 
phosphorylation and poly
which in turn recruits GSK-3β away from the 
degradation complex. This allows for 
stabilization of β-catenin levels, Rac1
dependent nuclear translocation and 
recruitment to the LEF/ TCF DNA
factors where it acts as an activator for 
transcription by displacement of Groucho
HDAC co-repressors. 
fromGregorieff and Clevers,  
Dev. 2005 Apr 15;19(8):877-90.
-Myc  
-
f 
-
Marson et 
). 
 The 
-3β from the 
-catenin, an 
-regulator, is 
-catenin by 
-3β leads 
 proteasomal 
-TrCP/SKP 
-ubiquitination, 
-
-binding 
- 
(Adapted 
Genes 
). 
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p53 pathway inhibition.p53 is an estabished tumor suppressor-protein whose 
malfunction is involved in most human cancers
165
. However, the role of p53 is not restricted to 
tumor prevention. In fact, several studies have shown that p53 plays an active role during 
development  thanks to its capability to inhibite or promote differentiation, depending on the 
cell type and lineage. For example, p53 knock-out mice are characterized by birth defects in 
neural tube closure, bone development and polydactyly
166
. 
p53 levels act as a fate switch between the mesodermal and ectodermal differentiation 
programs in vitro, redirecting differentiation from neuronal lineage to muscle when 
downregulated 
167
. Moreover,  p53 levels control  the pluripotency and differentiation of ES 
cells through the regulation of Wnt signalling
168
. Importantly, under stress conditions, p53  
inhibits the Nanog promoter toinduce differentiation in ES cells, sopreventing the  proliferation 
of damaged cells with unlimited self-renewing capacities
169
. 
A wide range of of stress signals (i.e. overexpression of oncogenes such as c-Myc
170,171
) activate 
p53, leading to cell cycle arrest, a program that induces cell senescence/cellular apoptosis
172
.  
Klf4 can either activate or antagonize p53 depending on the cell cycle target and the level of 
expression
173
(Fig.47). Therefore, overexpression of c-Myc and Klf4 oncogenes seems to activate 
the p53 pathway, leading to cell cycle arrest and/or to apoptosis, and ultimately to reduced 
reprogramming efficiency.  
These functional interactions among p53, cMyc, Klf4, Nanog may account for the well described 
capability of p53 to affect iPSCs generation. Recently, p53 has been demonstrated to play a 
crucial role in inducing pluripotency . In 2008, a a short-interfering RNA (siRNA) directed against 
the gene encoding for p53 (also known as TP53 in humans and Trp53 in mice) was described to 
enhance the efficiency of iPS cell generation by up to 100-fold, even when the oncogene c-Myc 
had been removed from the reprogramming gene combinations 
174
.  
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In 2009, five different worksshowed that the suppression or alteration of the p53 
pathwayenhances the efficiency of human iPS cell generation 
175–178
(see fig.48).These works are 
extremely interesting as they provide suggestions about a molecular tool, p53 downregulation, 
available to facilitate changes of tissue identity. 
 
Figure 47. (A) During development the p53 
pathway affect differentiation of ES cells to 
certain cell types. (B) The  reprogramming of 
somatic cells to iPS cells is inhibited by p53. The 
induction of the pluripotant state through 
introduction of the Yamanaka factors C-myc, 
Klf4, Oct4 and Sox2  leads to an activation of 
p53. The various outcomes of p53 activation 
(senescence, cell cycle arrest and apoptosis) 
decrease the reprogramming efficiency, 
thereby forming a negative feedback loop. 
Hence, the disruption of the p53 pathway 
increases the efficiency of reprogramming but, 
simultaneously, removes the “guardian” of 
genomic integrity, resulting in an increased 
mutational burden (not shown).(C) The 
reprogramming efficiency is reduced when 
passaging of somatic cells prior to 
reprogramming  is increased. In fact, it leads to 
senescence and cause an increasein  p21 and 
p19ARFlevels, which in turn promote cell cycle 
arrest and p53 activation, 
respectively(Adapted from Menendez et al.,Cell 
Cycle 9:19, 3887-3891; October 1, 2010 ). 
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However, inactivation or suppression of the p53 pathway to enhance reprogramming efficiency  
may pose serious problems, since p53 inactivation can contribute to tumorigenesis by 
propagation of genomic instability. Thus, inhibition or alteration of p53 pathway couldincrease 
the reprogramming efficiency in global terms, regarding number of cells reprogrammed, but 
not in terms of safety, as an altered p53 pathway could render iPS cells with genomic instability 
and tumorigenesis. For these reasons, p53 downregulation, albeit potentially useful, has to be 
considered with extreme caution for clinical use and exploitation. 
 
 
 
 
 
 
 
 
Figure 48. p53 and p21 
suppress iPS cell generation. 
The suppressive effects of 
these tumour suppressor 
gene products on cell 
proliferation, survival or 
plating efficiency should 
contribute to the observed 
effect In addition, they may 
have direct effects on 
reprogramming(Yamanaka,20
09).(Adapted from H. Hong et 
al., Nature460, 1132–1135 
,2009). 
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2.4. Direct transdifferentiation. 
 
Transdifferentiation is a naturally occurring mechanism that was first observed in the 
regenerating lens of the newt, over 100 years ago (Wolff, G.,1895)
252
. This process implies a 
dedifferentiation  step by which cells regress to a point where they can switch lineages and 
differentiate into another cell type (Fig.49).The ” artificial transdifferentiation”, also known as 
lineage reprogramming
180
has been more recently described  and is the process by which one 
mature somatic cell gets converted into another mature somatic cell by avoiding the  
intermediate pluripotent state.  
The first instance of transdifferentiation was reported in 1987 by Davis R.L. et al.,who showed 
 
 
 
 
 
Figure 49. Transidifferentiation : Natural and artificial. (Adapted from Jopling et al.,Nat Rev Mol Cell 
Biol. 2011;12:79–89). 
 
 
 
that expression of a myoblast-specific, subtracted cDNA transfected into mouse C3H10T1/2 
fibroblasts (where it is not normally expressed) is sufficient to convert them to stable 
myoblasts(fig. 50A). 
Subsequent studies showed that the erythroid megakaryocyte- affiliated transcription factor 
GATA1, when ectopically expressed in cell lines of monocytes (macrophage precursors) at high 
levels, induce the expression of erythroid-megakaryocyte lineage markers and also 
downregulate monocytic marker (fig. 50B). 
  
Figure50. Examples of cell fate switches achieved by transcription factor overexpression or ablation 
experiments(Adapted from Thomas Graf & Tariq Enver, 
 
 
 
More recently it was shown that 
factor C/EBPa, involved in the
convert committed B- and T-cell progenitors into functional macrophages at frequencies 
about 100%. Also mature immunoglobulin
frequencies 
181
 (Fig. 50C). Moreo
stabilized Pax5-deficient B cells into immunodeficient 
immunoglobulin rearrangements 
As easily predictable, the efficiency by which transcription factors induce lineage conversions 
depends on the proximity of the cell type in question 
factors acting at earlier common branch points. An explanatory example 
switching of hepatic progenitors into endocrine pancreas β
to switch exocrine pancreas cells
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Nature 462, 587-594,2009| doi:10.1038/nature08533
also fully differentiated cells can be switched: 
 formation of granulocyte-macrophage precursors
-producing B cells can be switched, 
ver, in 2007 it was demonstrated that transplantation of Bcl2
mice generates T cells, 
182
 (Fig. 50D). 
: greater distances may require additional 
is the observation t
-cells only requires Ngn3
, alsoPdx1 and MafA 
184
(fig. 50E) are require. 
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2.4.1. Direct reprogramming of mouse and human fibroblasts into functional neurons by 
defined factors. 
 
In 2010,there was a great breakthrough in the emerging field of transdifferentiation, when 
Marius Wernig and co-workers described for the first time the direct conversion of mouse 
fibroblasts into functional neurons, by defined factors 
185
. They screened 19 genes, specifically 
expressed in neural tissues or implicated in neural development, for their capability to induce 
this conversion. They found that just three factors (Brn2, Ascl1 and Myt1l, shortly "BAM")(see 
fig.51a)can rapidly and efficiently convert mouse fibroblasts (derived from Tau-EGFP transgenic 
mice) into functional "induced neurons" (BAM-iN cells), expressing MAP2,Synapsin and Tubb3 
(fig.51d-e-f). Moreover, individual analysis revealed that only ASCl1 can induce a neuronal 
phenotype in fibroblasts, albeit an immature one (fig. 51i). On the other hand, they also found 
that, although the single factor Ascl1 is sufficient to induce immature neuronal features, the 
additional expression of  Brn2 and Myt1l gives rise to iN cells with efficiencies up to19.5%. 
Moreover, three-factor iN cells display functional properties of mature neurons, such as the 
generation of trains of action potentials, integration into a preexisting neuronal network and 
iN-iN synapse formation(fig.51i). Finally, the most part of iN cells described by Vierbuchen et al. 
showed an excitatory phenotype and expressed the vesicular glutamate transporter 1 vGLUT1. 
Conversely, a lower proportion of them expressed markers of GABAergic neurons. 
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Figure 51. Induction of functional iN cells by 3 factors.(a)Breakdown experiments identificating the 3F pool that is 
sufficient to efficiently  generate iN cells (Adapted from Vierbuchen et al.,Nature. 2010 February 25; 463(7284): 
1035–1041). 
 
 
 
From this point on, several groups independently used the so-called BAM cocktail in addition to 
other neurogenic factors to directly convert fibroblasts into iNs
186–190
. 
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2.4.2.Generation of iN cells from human fibroblasts. 
 
Taking advantage of ectopic expression of the BAM cocktail, Pfisterer et al. 
188
could achieve the 
reprogramming of embryonic and adult human fibroblasts to human iNs (hiNs) with efficiencies 
of 16 and 4 %, respectively. They observed that the successful conversion of human fetal 
fibroblasts to immaturehiNs required 20 days of transgene expression. 
In the same year, Pang et al. showed that the BAM cocktail, when combined with the basic 
helix-loop-helix transcription factor NeuroD1, is also able to convert fetal and postnatal human 
fibroblasts into iN cells displaying typical neuronal morphologies and expressing multiple 
neuronal markers, even after downregulation of the exogenous transcription factors.  
Remarkably, the most part of these human iN cells were able to generate action potentials and 
to receive synaptic contacts when co-cultured with primary mouse cortical neurons
187
(fig. 52). 
 
 
 
Figure 52. Characterization of BAM+NeuroD1 
iNs derived primary human fetal fibroblasts. 
(a) Tuj1-positive BAM-iN cells + additional 
factors, quantified 3 weeks after transgenes 
activation. (b)Neuronal morphologies arising  
three weeks after doxy addition in  
BAM+NeuroD1 iN cells. (c) Tuj1 expression, 3 
weeks after doxy . (d–f) Expression of pan-
neuronal markers in  iN cells 2 weeks after 
dox. (g–h) Example of iN cell expressing MAP2 
(g) and synapsin (h) 4 weeks after dox and co-
cultured with primary astrocytes (Adapted 
from Pang et al., Nature476, 220–223 
(2011)). 
68 
 
2.4.3. Generating distinct functional subtypes of iN cells. 
 
Undoubtely, subtype-specific induced neurons, expecially if derived from human somatic cells, 
could be an extremely valuable tool for disease modeling and cell replacement therapy. For this 
reason, several Teams dedicated special efforts to address this issue. 
Induced Dopaminergic neurons (iDA). 
 
Transplantation of dopaminergic neurons can potentially improve the clinical outcome of 
Parkinson’s disease, a neurological disorder resulting from degeneration of mesencephalic 
dopaminergic neurons.Several groups have directly reprogrammed fibroblasts to induced 
dopaminergic neurons (iDA) by overexpressing dopamine neuron lineage-specific factors that 
act during brain development, including genes involved in midbrain dopamine neuron 
development. Among them, Pfisterer et al.
188
found that iNs can be directed towarddistinct 
functional neurotransmitter phenotypes by overexpressing the BAM cocktail with two genes 
involved in dopamine neurongeneration, Lmx1a and FoxA2(fig.53). In this way, they could 
direct the phenotype ofthe converted cells toward dopaminergic neurons.  
 
 
 
 
 
Caiazzo et al. identified a minimal set of three transcription factors—
Mash1 (or Ascl1), Nurr1 (or Nr4a2) and Lmx1a—that are able to directly convert mouse and 
Figure 53. Direct conversion of fibroblasts 
into specific neuronal subtypes. 
Two genes involved in midbrain dopamine 
neuron development , Lmx1a and FoxA2, 
optimize generation of 
human iDAs when added to the BAM cocktail. 
Mouse embryonic fibroblasts  are converted 
into functional iMN with an efficiency of 5–10 
%. The application of  the BAM cocktail with 
the addition of NeuroD1, to HEFs, is able to  
induce the generation of functional 
cholinergic iMNs in 2 weeks (Adapted from 
Abdullah A. I. et a.,Molecular Neurobiology 
June 2012, Volume 45, Issue 3, pp 586-595). 
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human fibroblasts into functional dopaminergic neurons
191
.So-induced dopaminergic (iDA) cells 
release dopamine and show the tipical pacemaker activity of brain dopaminergic neurons. 
TheMash1-Nurr1-Lmx1a cocktail induces dopaminergic neuronal conversion in prenatal and 
adult fibroblasts, from healthy donors and Parkinson’s disease patients. Direct generation of 
iDA cells from somatic cells might have significant implications for understanding critical 
processes for neuronal development, in vitro disease modelling and cell replacement therapies. 
 
Induced Motorneurons(iMNs) 
 
This neuron subtype can be efficiently derived from embryonic fibroblasts by adding to the 
BAM cocktail several combinations of seven known motor neuron-specific factors
189
:Lhx3, Hb9, 
Isl1, Ngn2 and Lhx3, Hb9, Isl1, Ngn2, NeuroD1 (fig.53). 
 
 
2.4.4. Direct generation of induced neural stem cells from fibroblasts. 
 
Although iN cells are functional neurons, they may not be very suitable to the study of certain 
neurological diseases, due not only to their non  proliferative state (which severely limits their 
numbers), but also to their inability to recapitulate disease phenotypes occurring at the neural 
progenitor stage 
192
. For this reason, many authors started focusing on an alternative way to 
generate neurons  based on the preliminary convertion of fibroblasts into iNSCs that, in a 
second step, can be differentiated in all neural cell type: astrocytes, oligodendrocytes and 
neurons(fig.54). 
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Figure 54. Convertion of fibroblasts into iNSCs(Adapted from Abdullah A. I. et a.,Molecular Neurobiology 
June 2012, Volume 45, Issue 3, pp 586-595). 
 
 
 Recently, several authors could achieve the direct convertion of fibroblasts into induced NSCs 
(iNSCs), bypassing the pluripotent stage 
193–196
. 
The first evidence of this process was described in 2011 by Kim and collaborators. They 
reported that transient induction of the four Yamanaka reprogramming factors (Oct4, Sox2, 
Klf4, and c-Myc) followed by cells exposition to neural reprogramming medium can efficiently 
transdifferentiate fibroblasts into functional neural stem/progenitor cells (NPCs)
126
. This 
transdifferentiation process is highly specific and efficient, reaching completion within 9–13 
days. If compared with the direct generation of iN cells, this method provides one critical  
advantage: the resulting cells are expandable progenitor cells. These reprogrammed NPCs were 
generated from both embryonic and adult TTFs. They expressed neural rosette markers (PLZF 
and ZO-1, fig. 55a), Pax6 (not shown) and were able to differentiate into Dcx-, TH-, GABA-, 
Map2-, NeuN-, and synapsin I-expressing neurons(Fig. 55 b-f). 
 
  
 
 
 
 
A further step onward was recently achieved by 
FoxG1 and Sox2 can induce NPCs ( “iNPCs”). The most part of these cells were  
generating clonal self-renewing, bipotent induced NPCs giving  rise to functional neurons and 
astrocytes
197
. Moreover, the addition of  the tra
induced tripotent NPCs, that could be differentiated into all three main derivatives of neural 
stem cells, neurons, astrocytes and oligodendrocytes. (
 
 
Figure 55. Neural progenitor induction from fibroblasts
(Adapted from Kim et al., Proc Natl Acad Sci USA 108:7838
2011). 
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Lujan et al.who found that the combination of 
nscription factor Brn2 to Sox2 and FoxG1, 
fig.56). 
.  
–7843, 
capable of 
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These data demonstrate that direct lineage reprogramming based on target cell-type–specific 
transcription factors can be used to induce NPC-like cells, potentially useful for autologous cell 
transplantation-based therapies in the brain or spinal cord. Nevertheless, at date,  an important 
issue is still far to be addressed: the generation of pure preparations of cortico-cerebral 
neurons. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56. Tripotent NPC population derived from Sox2-EGFP MEFs(A) A Sox2-EGFP+ population that gives 
rise to O4+ oligodendrocytes, Tuj1+ and MAP2+ neurons, and GFAP+ astrocytes (B) FoxG1 and Brn2 alone 
induce a population that can give rise to mature CNP+, Olig2+, and MBP+ oligodendrocytes, GFAP+ and 
S100+ astrocytes, and TUJ1+ and MAP2+ neurons.(Adapted from Lujan, E., Proc. Natl. Acad. Sci. 
U.S.A.109, 2527–2532, 2012). 
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CHAPTER 3.AIMS OF THESIS 
 
As described above, specification of cerebral cortex is the result of two superimposed 
processes: pan-neural specification of the neural tube and regional sub-specification of its most 
rostro-dorsal part. The former largely relies on inhibition of Bmp signaling and active Fgf 
signalling. The latter requires the combinatorial activation of specific transcription factors (TFs) 
imparting distinct positional values along the rostro-caudal and the dorso-ventral axes. 
Aim of this work was to assess if concerted co-expression of the main four TFs specifying rostro-
dorsal identity, Foxg1, Pax6, Emx2 and Lhx2, is sufficient to convert somatic non neural cells, 
such as dermal fibroblasts, into neural-like precursors, regardless of previous activation of a 
pan-neural program. 
This would allow to test the capability of positional identity machineries to trigger and sustain 
panneural programs. Reprogrammed cells originating from this procedure might represent on 
invaluable tool for patient-tailored cell therapy of brain diseases. 
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CHAPTER 4. RESULTS 
 
4.1. Setting up the "FPd" reprogramming procedure. 
 
 We assayed the capability of distinct combinations of pallium-specifying genes (Foxg1, 
Pax6, Emx2 and Lhx2, briefly: FPEL), to induce firing of the neural stem cell reporter Sox1
EGFP
 in 
derivatives of murine Sox1
EGFP/+
 fibroblasts
198
. These four genes were delivered via lentiviral 
vectors, as doxycycline-activatable transgenes. To propitiate Sox1
EGFP
 activation, we used 
fibroblasts derived from embryos knock-out for Trp53
199
 , an established promoter of 
histological homeostasis
200,201
, and exposed them chronically to a specific drug cocktail 
promoting transcription. This cocktail included 1 μM BIX-01294 (an inhibitor of the H3K27-
HMTase Ga9)
202
, 2μM trans-2-Phenyl-cyclopropylamine hydrochloride (t2PCPA, an inhibitor of 
the H3K4m2-demethylase LSD1)
203
 and 2 mM valproic acid (VPA, a HDAC inhibitor)
154,202
. 
[Actually, three additional drugs promoting transcription, the H3K9-HMTase inhibitor chaetocin 
202
, the DNA methylation antagonizer 5-azacytidine
154,202
 and its functional synergizer 
dexamethasone 
154
were also assayed. However, they resulted unacceptably toxic, at as less as 
50 nM, 2μM and 1μM, respectively, and were early discarded]. 12 days post transgenes 
activation (d12), frequency of EGFP
ON
 cells was about 1% upon delivery of the FPEL set and 
arose to 1.8% for its FPL subset, pointing to a detrimental effect of Emx2 against Sox1 promoter 
activation. FP, FL and PL gave frequencies of 21.3, 0.1 and 0.7%, further suggesting the 
opportunity to exclude Lhx2 from the reprogramming geneset and indicating the FP 
combination as the most promising one (Fig. 57A-C). As for temporal progression of 
Sox1
EGFP
activation, we found that, upon overexpression of the FP pair and in the presence of 
the VPA/BIX-01294/t2PCPA drug mix, frequency of Sox1
EGFP(ON)
 cells, almost 17% at d4, reached 
its plateau (around 21%) at d6, whereas average fluorescence intensity within the EGFP
ON
 
population continued to arise until at least d12 (Fig. 57D). 
 Then, we systematically dissected functional relevance of the main ingredients of the 
previously assayed, best performing protocol (hereafter referred to as "the FPd protocol"): the 
Foxg1/Pax6 pair (FP), the BIX-01294/t2PCPA/VPA drug mix (d) and the Trp53
-/-
 genotype of 
substrate cells. 
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Figure 57. Setting-up the "FPd" protocol. (A) Frequencies of Trp53
-/-
Sox1
EGFP/+
 cells expressing EGFP, 
following lentiviral transduction with different combinations of doxy-activatable reprogramming factor 
genes, each at moi = 12, as evaluated by FAC sorting 12 days after transgenes activation. (B) Example of 
FACS plot, referring to Trp53
-/-
Sox1
EGFP/+
 fibroblasts transduced by Foxg1/Pax6 (FP) or a negative control 
(NC). (C) Sox1 promoter-driven EGFP fluorescence in neurosphere-like aggregates of FP-transduced cells 
and NC fibroblasts. (D) Time-course progression of frequency of FP-transduced cells expressing EGFP 
and the corresponding signal intensity. au = arbitrary units. 
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Figure 58. Dissecting contributions of TFs-ratio, drugs and Trp53 to fibroblasts reprogramming (A) 
Frequency of EGFP expressing cells and EGFP signal intensity, upon lentiviral delivery of Foxg1 and Pax6 
at different moi's, as evaluated by FACS, 7 days after transgenes activation. (B) Functional break-down 
of the drug mix promoting fibroblasts reprogramming. (C) Specificity of drugs effects. In (B,C), for each 
drug combination, frequency and signal intensity are reported as in (A). Cells were transduced by Foxg1 
and Pax6 and monitored 6 of 8 days after transgenes activation. (D) Impact of Trp53 genotype and drugs 
(BIX-01294, 2-PCPA, VPA) on the efficiency of the reprogramming process, at day 4 and day 6. 
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 First, we found that Sox1
EGFP
 activation strictly requires over-expression of both Foxg1 
and Pax6. In fact, in the presence of the full drug mix and in a Trp53
-/-
 environment, Foxg1 
alone did not give any appreciable fraction of Sox1-EGFP
ON
 cells, which conversely amounted to 
as little as 0.4% under Pax6 only. Moreover, the protocol output resulted sensitive to relative 
dosages of Foxg1- and Pax6-expressing lentiviruses. At d7, the best result, 25.1%, was obtained 
with a 1:1 Foxg1:Pax6 lentivirus stochiometry, whereas EGFP
ON
 cells were only 13.9% and 
21.7% with 2:1 and 1:2 F/P ratios, respectively. Similar results were obtained when the total FP 
moi, 24, was halved, which also caused some slight frequencies dowregulation (Fig. 58A).  
Second, we found that the VPA/BIX-01294/t2PCPA drug mix, while not sufficient per se to 
trigger Sox1
EGFP
 expression, considerably enhanced the activity of the FP pair, expecially during 
early phases of the process. In a dedicated test, upon administration of Foxg1- and Pax6-
expressor lentiviruses each at moi = 12, frequency of Sox1-EGFP
ON
 cells resulted 1.9% and 5.6% 
in the absence of drugs, at d4 and d7, respectively, and arose to 16.9 and 22.1% in their full 
presence. VPA was apparently the main contributor, as this frequency went back to 2.2% upon 
its selective removal from the drug mix and bounced to 24% under VPA only. However, as in 
this last case the average signal intensity was only 2/3 of that elicited by the full drug mix, we 
decided to retain BIX-01294 and t2PCPA in the standard "d" cocktail, to be emplyoyed in 
subsequent experiments (Fig. 57F). Remarkably, effects of VPA resulted to be highly specific. In 
fact, when "d" was replaced by 0.5 mM Na-butyrate (another established HDAC inhibitor), 
frequency of Sox1-EGFP
ON
 cells at d8 dropped to as less as 3.6% (Fig. 58C). 
 Third, as for Trp53, we found that itsinactivation makes substrate cells much more 
prone to get reprogrammed. Upon delivery of the "FPd" protocol, in fact, Sox1-EGFP
ON
 
elements were 2.4% and 16.9% at d4, and 3.5% and 22.1% at d6, starting from Trp53-wt and 
Trp53-null fibroblasts, respectively. However, the intensity of Sox1-EGFP fluorescence was 
considerably higher in Trp53-wt than in Trp53-ko cells, further suggesting that, after 
recruitement of cells to the reprogramming process, Trp53 might help canalizing them into a 
NSC-like state. Remarkably, there was also some addition of drugs and genotype effects, as, in 
the absence of drugs, only 2.2% of d6 derivatives of infected Trp53-wt fibroblasts expressed 
EGFP (Fig. 58D). 
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 Finally, we tried to ameliorate NSC-like outputs of our "FPd" procedure by super-
imposing to it select gene manipulations, supposed to help mimicking the dynamical 
transcriptional milieu of the early pallial field
204,205
. However, neither delayed overexpression of 
Emx2 and Lhx2, nor early overexpression of two key hubs sustaining NSC programs
206–208
, Sox2 
and Brn2, were successful (Fig. S1A, B). Moreover, we tried to facilitate reprogramming, by 
counteracting the heat-shock machinery, known to promote phenotypic canalization within the 
ontogenetic and homeostatic domains
209,210
.Three approaches were used. We: (a) kept 
Sox1
EGFP/+
;Trp53
-/-
 fibroblasts 2 hours at 41°C(13); (b) exposed them to 1μM 17-(allylamino)-17-
demethoxygeldanamycin (17AAD, a powerful hsp90 inhibitor) 
211
 for 24 hours; (c) treated them 
by 1μM 17AAD/1μM CAY10603 (a HDAC6 inhibitor, synergyzing 17AAD
212
) again for 24 hours. 
When these treatments were combinatorially superimposed to our best performing protocol 
"FPd", 46 and 24 hous after transgenes activation, respectively, we did not elicit any 
upregulation of the Sox1-EGFP
ON
 fraction, which was conversely halved by the harshest, fully 
combined treatment. However, in such a case EGFP fluorescence intensity, as evaluated by 
FACS profiling, was upregulated by circa one quarter within the Sox1-EGFP
ON
 population. This 
suggests that knock-down of the heat shock machinery, albeit poorly useful to enroll more 
fibroblasts to get reprogrammed, might sustain the reprogramming process, once it has been 
triggered (Fig. S1C). 
 
4.2. Molecular characterization of NSC-like elements. 
 
 To confirm the conversion of fibroblasts into NSC-like elements, we inspected them for 
selected NSC markers. We found that at d13 about 20% of FP-treated cells were 
immunoreactive for Sox2, albeit at low level (Fig. 59A). Moreover qRTPCR profiling of the same 
cells revealed that Pax6 and Hes5, almost undetectable in negative control MEFs, were 
upregulated up to 40% and 25% of levels peculiar to derivatives of E12.5 cortico-cerebral 
precursors, respectively (Fig. 59B,C). 
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Figure 59. Molecular characterization of FPd-reprogrammed Sox1
 EGFP/+
 cells. (A) Expression of Sox1-EGFP, Sox2 
and Tubb3, in FP-treated and NC cells, as evaluated by immunofluorescence. (B-D) RTPCR quantitation of Pax6, 
Hes5 and Neurog2 mRNAs, in (1) FPd-treated fibroblasts at day 13, and (2) control neural stem cells (NSCs) from 
E12.5 cortico-cerebral precursors kept 4 days in vitro (E12.5+DIV4). 
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We also noticed a weak expression of Tubβ3 in about 15% of FP-treated cells (Fig. 59A), namely 
a promising index of neuronogenic potential. However, Neurog2, a key determinant of the 
glutamatergic lineage directly activated by Pax6, was expressed at similar low levels in both FP-
treated and negative control MEFs (Fig. 58D). 
 To preliminarly evaluate reprogramming advancement, we assayed cells resulting from 
this process for their capability to sustain firing of the NSC-specific Sox1 promoter, upon 
switching off the exogenous reprogramming geneset. For this purpose, we delivered the "FPd" 
protocol to two batches of Trp53-ko fibroblasts, harboring the EGFP cds alternatively under the 
control of the NSC-restricted Sox1 promoter or the doxy-responsive TREt promoter (Fig. 60A, i 
and ii, respectively), the latter further expressing the artificial transactivator rtTA
2S
-M2. We 
removed doxycycline at d13 and scored subsequent decay of  EGFP fluorescence. At d20, 
average EGFP intensity dropped to only 17% of the d13 value in Sox1-wt/TREt-EGFP samples, 
remaining above 65% in Sox1
EGFP/+
 preparations (Fig. 60C). This suggests that, after switching 
the reprogramming transgenes off, some Sox1-promoter-driven neo-synthesis of EGFP occurred 
in reprogrammed Sox1
EGFP/+
 cultures. However, in the same timeframe, the frequency of Sox1-
EGFP
ON
 cells was reduced in these cultures about 12-fold, further suggesting that only a small 
subset of reprogrammed cells retained their new state (Fig. 60B). 
 
4.3. Neuronogenic potential of Foxg1/Pax6-reprogrammed fibroblast 
derivatives. 
 
 Next, we wondered whether neural-like elements generated by combined Foxg1/Pax6 
overexpression were also able to activate neuronal markers. For this purpose, we delivered our 
best performing "FPd" protocol to Tau-EGFP
+/-
;Trp53
-/-
 fibroblasts
199,213
. At d6 we transferred 
the engineered cells to a B27/VPA-based medium ("neural differentiating medium"), in order to 
promote neuronal differentiation. Finally, 8 days later, we evaluated the frequency of EGFP 
expressing cells by FACS scanning. This frequency resulted to be 6.6%, suggesting that a subset 
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of the infected population could have acquired neuronal identity. No EGFP activation took 
conversely place in negative controls. We reasoned that the other two members of our original  
 
 
Figure 60. Assessing stability of NSC-like cells originating from FPd-treated fibroblasts. (A) Experimental design, 
including genotypes of the two cell preparations subject of analysis (i and II) and the doxycyclin administration 
schedule. (B,C) Frequencies of Sox1-EGFP-expressing cells and EGFP expression levels (within the expressing 
subpopulation) at days 13-20. For each cell preparation, frequencies and intensities are normalized against day 13 
values. 
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geneset, Emx2 and Lhx2, previously shown to promote neuronal differentiation in a variety of 
experimental contexts 
214–217
, might ameliorate the neuronal output of our manipulations. As 
expected, additional Emx2/Lhx2 overexpression, from d7 to d14, increased the Tau-EGFP
ON
 
fraction to 11.8% ("FPd/ELv" protocol). Moreover, the EL pair resulted far more neuronogenic 
than the established neuronogenic promoter Ascl1
185,187
. In fact, when Ascl1 was added to the 
EL pair, the Tau-EGFP
ON
 fraction resulted only slightly upregulated (13.5%), when cells were 
superinfected by Ascl1 alone, such fraction dropped back to 5.8%. Finally, as doxycyclin was 
removed from FPd/Ascl1-treated (FPd-A) samples at d7 (so resulting into a 
Foxg1
OFF
Pax6
OFF
Ascl1
ON
 configuration at d7-d14), the Tau-EGFP
ON
 fraction fell just above zero, 
further confirming the intrinsic neuronogenic activity of the FP pair (Fig. 61A,B). As a control, 
FACS analysis of Tau-driven EGFP expression was backed by EGFP immunodetection, which 
gave consistent results (Fig. 61C). 
 We tried to ameliorate the neuronal output of the above described two-steps "FPd/ELv" 
protocol, by exposing fibroblasts to four select drugs, known to promote their 
transdifferentiation into neuronal cell types 
218
 or synergize with VPA
219
. Remarkably, co-
inhibition of BMP- and TGFβ-signalling by 10μM SB431542 and 0.7 μM LDN193189, from d2 to 
d13, almost doubled the frequency of Tau-EGFP
(ON)
 cells. Therefore we included SB431542 and 
LDN193189 into an improved version of our protocol, we named "FPd/ELv
+"
. Conversely, 
stimulation of beta-catenin signaling by 0.7 μM BIO, in the same time window, as well as 
delivery of 25 μM vitamin C, from d2 to d14, approximately halved this frequency. Moreover, 
no advantage emerged from the addition to the "differentiating medium" of further drugs 
known to stimulate neuronal maturation (5μM forskolin, 5μM all-trans retinoic acid (atRA), 
30mM KCl, 25μM glutamic acid, 200μM beta-hydroxyanisole (bHA) or 1mM beta-
mercaptoethanol (bME)). Only 2% dimethyl-sulfoxide (DMSO) upregulated the TauEGFP
(ON)
 cells 
frequency, however by only one third (Fig. S2). 
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 Then to evaluate the extent of neuronal differentiation elicited with the FPd/ELv
+
 
protocol, we immunoprofiled cells reprogrammed by this protocol for selected markers 
expressed in mature neurons. We confirmed high level expression of Tau promoter-directed  
EGFP. However, MAP2 and NeuN were not detectable, suggesting a severe defect of neuronal 
differentiation (Fig. S3). We speculated that exposing reprogrammed cells to histogenetic clues 
active in the developing brain might help fixing this issue. Therefore, we infected cells 
originating from Trp53
-/-
Tau
EGFP/+
 donors with FP viruses, made them EL-GOF ad d6 and 
transplanted them at d13 into the fronto-parietal cortex of P0 recipient mice. 1-3 weeks later, 
we monitored their distribution and profile. Differently from positive controls (i.e., natural 
cortico-cerebral precursors), which consistently shed around the injection point, reprogrammed 
elements preferably clustered in big subventricular clumps near the corpus callosum. Like in 
vitro, they activated Tau-EGFP, but not MAP2 or NeuN, so confirming the uncapability of the 
FPd/ELv
+
 protocol to sustain full neuronal differentiation (Fig. S4). 
 Finally, electrophysiological experiments were performed to assess whether FPd/ELv
(+) 
cells exhibited a neuron-like phenotype. Comparison of Tau-EGFP positive and control cells in 
vitro revealed different characteristics in their passive and active membrane properties. We 
measured first the capacitance, the membrane input resistance, and the resting membrane 
potential (RMP), widely accepted indicators of the degree of cellular development and health in 
19 controls and 25 FPd/ELv
(+) 
cells. A significant more negative value of the RMP was detected 
in Tau-EGFP positive cells respect to control fibroblasts (-41 ± 2 mV and -22 ± 4 mV, 
respectively; p<0.001) (Fig. 62A). 
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Figure 61. Setting-up 
and improving the 
FPd/ELv protocol. (A) 
Frequencies of Trp53
-/-
Tau
 EGFP/+
cells expressing 
EGFP, following lentiviral 
transduction of doxy-
activatable Foxg1 and 
Pax6 and constitutively 
expressed Ascl1, each at 
moi = 6. Doxycyclin was 
administered in different 
time windows, between 
day 0 and day 13. Cells 
were analyzed by FAC 
sorting at day 13. (B) 
Example of FACS plot, 
referring to fibroblasts 
transduced by 
Foxg1/Pax6 (FP) or a 
negative control (NC). 
(C) Tau promoter-driven 
EGFP fluorescence in FP-
transduced and NC 
fibroblasts. (D) Effects of 
the combinatorial 
administration of four 
select drugs on the 
frequency of Trp53
-/-
Tau
EGFP/+ 
FPd/ELv-treated 
cells expressing EGFP, at 
day 13.  
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In addition, Tau-EGFP positive cells exhibited higher membrane capacitance (112 ± 16 pF versus 
48 ± 8 pF; p=0.023) (Fig. 62A) which, as expected, was associated with a reduction in 
membrane input resistance (272 ± 55 MΩ and 340 ± 104 MΩ, in Tau-EGFP positive cells and 
control respectively; p>0.05), that did not reach a statistical value (Fig. 62A). Interestingly, while 
in control cells the voltage/current relationship was linear (n=18), in  Tau-EGFP positive cells 
rectified in the depolarizing direction(Fig. 6B). Injection of a depolarizing current pulse of 200 
pA, from a holding potential of -70 mV (subthreshold for spike activation) produced in Tau-
EGFP positive cells a voltage deflection of -47 ± 3 mV instead of -26 mV,  (expected value 
obtained by interpolating data at negative potentials; n=18). Moreover, while in control cells 
depolarizing current pulses failed to evoke spikes (18/18), in the majority of Tau-EGFP positive 
cells (19/25; 76%) they were able to evoke rudimentary action potentials, reminiscent of those 
observed in immature neurons (Fig. 62B). The difference between the two groups was 
statistically significant (p<0.001; Chi Square test).  In three cases (out of six tested), the action 
potentials were blocked by TTX (1 µM), indicating that they were generated by the activation of 
voltage-dependent sodium channels. Overall these results suggest that the FPd/ELv(+) protocol 
channels fibroblasts towards a neuronal profile. 
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Figure 62. Neuron-like phenotype of FPd/ELv
+
 fibroblasts. (A) Each column represents the mean capacitance (C), 
input resistance (Rin) and resting membrane potential (RMP) values of control (black) and reprogrammed  
fibroblasts (white). (B) V/I relationship  obtained by injecting depolarizing and hyperpolarizing current pulses of 
increasing amplitude from a holding potential of -70 mV (0 current) in controls (n=18; black symbols, left) and in 
FPd/ELv
(+) 
cells (n=18; white symbols, right). Note rectification in the depolarizing direction in FPd/ELv
(+) 
cells. On 
the left of  of the V/I relationships, single sample from controls and FPd/ELv
(+) 
cells (C) Examples of a single control 
and reprogrammed FPd/ELv
(+) 
cell. 
87 
 
CHAPTER 5. DISCUSSION 
 
 We found that a selection of TFs dictating pancortical specification was able to convert 
non-neural somatic cells (fibroblasts) into neural stem cell-like (NSC-like) elements. The 
efficiency of this process was strongly increased by two classes of additional manipulations: (1) 
administration of drugs modulating the epigenetic state of chromatin and promoting 
transcription; (2) inactivation of the p53 pathway, stabilizing tissue identity. Inhibition of TGFβ 
and BMP pathways further upregulated NSC-like cells frequency, up to 30% (data not shown). A 
small fraction of NSC-like elements resulting from combined treatments (1) and (2) were able to 
maintain their identity, even after switching off the reprogramming transgenes(fig. 60). These 
NSC-like elements, when cultured under pro-differentiative conditions, gave rise to neuron-like 
cells, expressing EGFP under the control of the Tau promoter. Frequency of neuron-like cells 
was enhanced by overexpression of the two TFs Emx2 and Lhx2 and tonic inhibition of TGFβ 
and BMP signallings. These Tau-EGFP(ON) cells showed a negative resting potential and 
displayed active electric responses, following injection of depolarizing currents. However their 
neuronal differentiation was largely defective, both in vitro and in vivo. Moreover no sign of 
glial differentiation was detected (data not shown). 
 The capability of Foxg1 and Pax6 to synergistically stimulate conversion of fibroblasts to 
neural precursor-like elements is consistent with the patterning activities displayed by these 
two genes in the developing neural tube: specifiction of telencephalic versus diencephalic 
identity by Foxg1
220
, and promotion of dorsal versus ventral telencephalic programs by Pax6 
221,222
. It is also consistent with the previously reported ability of these two genes to neuralize 
non neural tissues in vitro. In fact, Pax6 overexpression in HeLa cells induces a partial 
transdifferentiation towards a neuronal phenotype
223
, combined overexpression of Foxg1 with 
Sox2 and Brn2 converts fibroblasts to tripotent neural precursors
197
. 
 Moreover, we found that Foxg1 and Pax6 are further able to promote the generation of 
neuron-like elements, displaying active electrical properties (Fig. 62). Even this result reflects 
histogenetic activities already characterized in vivo. In fact, high levels of Pax6 trigger cortical 
neuronogenesis
224
,Foxg1, strongly expressed in neocortical neurons, stimulates their 
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postmitotic maturation
225
. Notably, Emx2 and Lhx2, although promoting pancortical 
specification in vivo
221,222,226
, were strongly detrimental to early steps of fibroblasts 
reprogramming, when overexpressed together with Foxg1 and Pax6 (Fig. 57A). This could be 
related to their alternative involvement in mesenchymal development. For example, Emx2 
specifies mesodermal structures, such as scapula and urogenital system 
227–229
, while Lhx2 
channels ESCs and iPSCs towards the hematopoietic lineage
230
. Notably, however, delayed 
overexpression of these two genes in elements already reprogrammed by Foxg1 and Pax6 
enhanced their neuron-like differentiation (Fig. 61A). This parallels later promotion of neuronal 
differentiation elicited by both genes in vivo
215–217,231
. Remarkably, a specific mix of 
"epigenetic drugs" increased the NSC-like output of the FP protocol by 4- to 8-fold (Fig. 58B). It 
has been proposed that stability of tissue identity largely relies on retention of specific 
epigenetic signatures, dictating differential gene availability to transcription and preventing 
improper gene expression 
232
. We employed VPA, BIX-01294, and t2PCPA, hypothesizing that 
chromatin opening promoted by these drugs could facilitate the access of neuralizing TFs to 
target genes, usually hidden in non neural tissues. This concept is consistent with previous 
reports of VPA- and BIX-01294-dependent enhancement of iPSCs generation
233,152
. Interestingly 
the effects of VPA were highly specific, as this drug could not be vicariated by another 
established HDAC-inhibitor, Na-butyrate (Fig. 58C). This might reflect the exquisite capability of 
VPA to upregulate bHLH neuronogenic genes 
234
. On the other side, Na-butyrate might divert 
infected fibroblasts to iPSCs identities, by promoting the expression of endogenous 
pluripotency-associated genes
235
. 
 Moreover, the NSC-like output of the FP protocol was also dramatically increased by 
genetic ablation of p53 (Fig. 58D). This result echoes the effects of Trp53 knock-out on iPSCs 
generation
179,201
 a phenomenon suggested to be underlain by two main mechanisms. First, p53 
downregulation may be a key step of the chain of events leading to iPSC generation
236
. Second, 
p53 inactivation may prevent apoptosis induced by functional interaction between p53 itself 
and reprograming oncogenes
201
. Since Foxg1 itself may act as an oncogene
237
, p53 knock-out 
might increase the frequency of Sox1
EGFP(ON) 
elements, just preventing fibroblasts from cell 
death triggered by its sustained overexpression. 
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 We found that combined inhibition of Tgfb and Bmp signalling doubled the neuronal-
like output of our FPd/EL protocol, while stimulation of Wnt signalling and administration of 
vitamin C halved it. The first phenomenon is consistent with previously documented activities 
of these signalling systems in vivo and in vitro. In fact, within the developing embryo, Wnt, Tgfb 
and Bmp signalling promote epiblast conversion to endoderm and mesoderm
238,239
, early 
activation of Wnt signalling and inhibition of Bmp4 promote neural at expenses of ectodermal 
fates
240,241
. Consistently, in vitro combined stimulation of Wnt pathway and inhibition of Bmp 
and Tgfb signalling strongly promote transdifferentiation of human fibroblasts to neurons
218
. 
 Detrimental effects of Wnt signalling and vitamin C on neural transdifferentiation 
efficiency were conversely unexpected. It is possible that high Wnt signalling promoted 
fibroblasts self-renewal
242,243
, so diluting reprogrammed cells. Moreover, Wnts, in the presence 
of residual Bmp/Tgfb signalling, might force transdifferentiating fibroblasts towards meso-
endodermal fates. Finally, as for vitamin C, it was previously shown to enhance full 
reprogramming of fibroblasts to iPSCs
219
, acting as key cofactor of histone demethylases which 
sustain the ESC master transcription factor Nanog
244
. As such, it might facilitate diversion of 
infected fibroblasts towards a pluripotent state. 
 Finally, it has to be underlined that, despite of activation of specific neuronal markers 
(Tubb3 and Tau-driven EGFP, see Fig. 59 and 61) and appearence of active electrical responses 
(Fig. 62), neuron-like differentiation elicited by the FPd/ELv+ protocol was highly defective, as 
the expression of established pan-neuronal markers (NeuN and MAP2) was completely missing. 
In this respect, we noticed that Neurog2, a key activator of the cortico-cerebral glutamatergic 
program
90
, was not upregulated in reprogrammed fibroblasts cultures (Fig. 59D), even in the 
presence of its direct activator Pax6
93
. We speculated that such missing upregulation might be 
responsible for defective neuronal differentiation. However, forced overexpression of Neurog2 
(and its paralog Ascl1) in FPd-reprogrammed fibroblasts did not activate MAP2, even upon 
inclusion of forskolin into the differentiation medium (data not shown). This implies that 
further molecular defects prevented proper execution of the neuronogenic program in these 
cells. We further hypothesized that absence of p53 could be a major issue. In fact, p53 
promotes conversion of early neural precursors to neuronal progenitor cells, by antagonizing 
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expression of Id1
245
. Moreover, it is required for advanced neuronal maturation, stimulating 
transcription of pro-neurite and axon-outgrowth genes Coronin 1b, Rab13 and GAP43
246,247
. 
Finally, knock-down of p53 by RNAi redirects retinoic acid (RA)-induced ESCs differentiation 
from neuronal to mesenchymal 
167
. For these reasons, we delivered the full FPd/EL+ protocol to 
Trp53 wild type fibroblasts. However, even in this case, no MAP2 activation was detected (data 
not shown). 
 In the light of these findings, an unbiased approach, based on comparative 
transcriptomic profiling of our FPd-induced elements and cortico-cerebral NSCs, seems 
necessary, to clarify molecular mechanisms underlying the histogenetic block undergone by 
such elements. This approach should provide a reasonable number of additional candidate 
genes, whose concerted modulation might fix defective neuronogenesis. We plan to implement 
this approach in dedicated follow-up study. 
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CHAPTER 6. CONCLUSIONS 
 
In synthesis, we have shown that a subset of TFs specifying rostro-dorsal identity, including 
Foxg1 and Pax6, is sufficient to convert mouse embryonic dermal fibroblasts into neural-like 
precursors, even in the absence of previous activation of the pan-neural program. 
These precursors express key NSC-markers, such as Sox1, Sox2, Hes5 and Pax6, and retain their 
new identity to some extent, even after switching off exogenous Foxg1/Pax6 expression. The 
same cells, following secondary overexpression of other two cortex-specifying genes, Emx2 and 
Lhx2, give rise to neuron-like elements, expressing the neuronal marker Tau and displaying 
active electrical properties. However, molecular and electrical profiles of these cells indicate 
that their neuronal differentiation is still rudimentary and incomplete. Comparative 
transcriptional profiling of these cells and their natural neural counterparts might help 
identifying molecular mechanisms underlying their defective differentiation. Such profiling will 
be subject of a dedicated follow-up study. 
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CHAPTER 7. MATERIALS AND METHODS 
 
7.1. Animal handling, generation and genotyping of compound mutants. 
 
Trp53
-/+
 (a kind gift by G. Del Sal, CIB, Trieste, Italy), Tau
EGFP/+ 
(purchased from Jackson 
Laboratories, USA) and Sox1
EGFP/+ 
 mice (a kind gift by A. Smith, University of Cambridge, UK) 
used in this study were maintained at the SISSA mouse facility. Embryos were staged by timed 
breeding and vaginal plug inspection. Double-mutant lines were generated by mating mice 
harboring Trp53
-199
,Tau
EGFP248
, or Sox1
EGFP198
mutant alleles, in different combinations. Trp53
-/- 
females were ruled out from the breeding scheme, as sterile. The offspring genotype was 
determined by multiplex PCR. The following primers were employed :   fwdX6: 5’-
AGCGTGGTGGTACCTTATGAGC-3’, RevX7: 5’-GGATGGTGGTATACTCAGAGCC-3’, RevNeo19: 5’-
GCTATCAGGACATAGCGTTGGC-3’ for Trp53 line; PR385lu02 5' TGG TGA ACC GCA TCG 
AGC TGA  AG 3', PR386lu02 5' AAC TCC AGC AGG ACC ATG TGA TGC 3', MG-S 5' CCC CCA 
AGT TGG TGT CAA AAG CC 3', MG-AS 5' ATG CTC TCT GCT TTA AGG AGT CAG 3' for EGFP-
reporter lines. 
 
7.2. Primary cell cultures. 
 7.2.1. Mouse embryonic fibroblasts cultures. 
 
Trp53KO;Sox1-EGFP and Trp53KO;Tau-EGFP MEFs  were isolated from E14.5 embryos under a 
dissection microscope (Leica). The head, vertebral column (containing the spinal cord), dorsal 
root ganglia and all internal organs were removed and discarded to ensure the removal of all 
cells with neurogenic potential from the cultures. The remaining tissue was manually 
dissociated and incubated in 0,05 % trypsin (Sigma) for 10–15 min to create a single cell 
suspension. The cells from each embryo were plated onto a 10-cm tissue culture dish in MEF 
media (Dulbecco’s Modified Eagle Medium; Invitrogen) containing 10% fetalbovine serum 
(FBS), and penicillin/streptomycin. Cells were grown at 37 °C for 3-4 days until confluent, and 
then split once before being frozen. After thawing, cells were cultured on 10-cm plates and 
allowed to become confluent before being split onto plates for infections using 0.05% trypsin. 
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 7.2.2. Cortico-cerebral neuronal cultures. 
 
The cortical tissue from E15.5-E18 mice was chopped to small pieces for 5-8 minutes, in the 
smallest volume of ice-cold 1X PBS-0,6% glucose-0,1% DNaseI. After digestion with 1mg/ml 
trypsin for 5 minutes,  cortices were spinned down and resuspended in Neurobasal medium 
containing 1X B27, 0,5mM glutamine, 25µ�βMercaptoethanol,1X penicillin/ streptomycin. After 
pipetting 5-8 times with P1000 gilson pipette, undissociated tissue was left to sediment? for 2 
minute at 1g, in ice. The supernatant was harvested and the living cells counted. Cells were 
resuspended at a concentration of 100-200/μl and plated on Poly-L-Lysine coated 24 Multiwell. 
 7.2.3. Cortico-cerebral precursors cultures. 
 
NSCs were isolated from E12  embryonic cortices and plated onto uncoated 24 multiwell (BD 
Falcon) after gentle mechanical dissociation to single cells. 2.5*105 cPCs were plated for each 
well in 350 μl of serum free anti-differentiative medium [1:1 DMEM-F12, 1X Glutamax (Gibco), 
1X N2 supplement (Invitrogen), 1 mg/ml BSA, 0.6% w/v glucose, 2 μg/ml heparin (Stemcell 
technologies), 20 ng/ml bFGF (Invitrogen), 20 ng/ml EGF (Invitrogen), 1X Pen/Strept (Gibco), 10 
pg/ml fungizone (Gibco)] added with 2μg/μl doxycycline (Clontech). 
 
7.3. Lentiviral transfer vectors construction. 
 
 Basic DNA manipulations (extraction, purification, ligation) as well as bacterial cultures 
and transformation, media and buffer preparations were performed according to standard 
methods. Plasmids were grown in E.Coli, Xl1-blue or TOP10 strains. A description of each 
transfer vector construction follows. 
 LV_Pgk1p-rtTA
2S
-M2 is the "driver lentivirus"described in Fig. 1C of ref
249
. 
 LV_TREt-Foxg1 was constructed by transferring the Foxg1-cds BamHI-HpaI fragment 
from LTV_TREt-Foxg1-IRES2EGFP
216
 into BamHI-HpaI cut LV_TREt-Pax6-IRES2EGFP, followed by 
deletion of the IRESEGFP fragment via SalI-BamHI digestion, filling in and religation. 
 LV_TREt-Pax6 was generated in two steps: (1) The BamHI(filled)-XhoI 1.9kb fragment 
from the clone sc-35 (a kind gift by Anastassia Stoykova), corresponding to Pax6-cds (short 
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form) plus circa 570 bp from the 3'UTR (nt 813-2729 of  Genbank # NM_013627.5), was 
transferred into the PmeI-XhoI cut  LV_TREt-IRES2EGFP vector (which is the empty "expressor 
lentivirus" described in Fig. 1C of ref
249
), giving rise to LV_TREt-Pax6-IRES2EGFP; (2) then the 
IRESEGFP module was deleted via SalI digestion and religation. 
 LV_TREt-Lhx2 was generated in two steps: (1) The BamHI(filled)-XhoI 1.2kb fragment, 
corresponding to the Lhx2-cds (Genbank # NM_010710, nt192-1412) was transferred into the 
PmeI-XhoI cut LV_TREt-IRES2EGFP vector; (2) then the IRESEGFP module was deleted via SalI 
digestion and religation. 
 LV_TREt-Emx2 was a kind gift of Clara Grudina. It was generated by transferring the 
NotI(filled)-XhoI 0.8kb fragment, corresponding to the Emx2 cds (Genbank # NM_010132, nt 
527-1288), into the PmeI-SalI cut LV_TREt-IRES2EGFP vector. 
 LV_TREt-luc was generated starting from LTV_TREt-luc-IRES2EGFP
216
  by deleting the 
IRES2-EGFP fragment via SalI digestion and religation. 
 LV_TREt-Sox2 is the plasmid TetO-FUW-sox2 described in ref 
250
 and corresponds to 
plasmid #20326 of the Addgene collection. 
 LV_TREt-Brn2 is the plasmid Tet-O-FUW-Brn2 described in ref 
185
 and corresponds to 
plasmid # 27151 of the Addgene collection. 
 LV_Pgk1p-Ascl1 is the plasmid LV_pSIN-WP-mPGK-hMash1, a kind gift by E.Capowsky 
and Clive Svendsen.  
 LV_Pgk1p-Neurog2 is the plasmid "Ngn2" described in
188
  and corresponds to plasmid 
#34999 of the Addgene collection. 
 
7.4. Lentiviral vectors packaging and titration. 
 
 Third generation self-inactivating (SIN) lentiviral vectors (all except LV_TREt-Sox2) were 
produced as previously described (Follenzi and Naldini, 2002) with some modifications. Briefly, 
293T cells were co-lipofected (Lipofectamine 2000, Invitrogen) with the transfer vector plasmid 
plus three auxiliary plasmids (pMD2 VSV.G; pMDLg/pRRE; pRSV-REV). In case of LV_TREt-Sox2, 
a 2nd generation lentivirus, the helper plasmids pMDLg/pRRE; pRSV-REV were replaced by 
95 
 
psPAX2. The conditioned medium was collected after 24 and 48hs, filtered and ultracentrifuged 
at 50000 RCF on a fixed angle rotor (JA 25.50 Beckmann Coulter) for 150 min at 4°C. Viral 
pellets were resuspended in PBS without BSA (Gibco). 
 Other LTVs were generally titrated by Real Time quantitative PCR after infection of 
HEK293T cells, as previously reported
251
. One end point fluorescence-titrated LTV was included 
in each PCR titration session and PCR- titers were converted into fluorescence-equivalent titers 
throughout the study. 
 
7.5. Reprogramming protocol. 
 
 Depending on the experimental goal, passage 2 mouse embryonic fibroblasts (P2 MEFs), 
harboring different Trp53
+/+
 vs Trp53
-/-
, Sox1
+/+
 vs Sox1
+/EGFP
, and Tau
+/+
 vs Tau
+/EGFP
 genotypes, 
were reprogrammed as follows. 
 7.5.1.From fibroblasts to NSC-like cells. 
 
Aliquots of 2*10
5
 MEFs were plated on 3.5cm∅ petri dishes (Nunc), as single cell suspensions in 
MEF medium (90% DMEM, 10% FBS, 1X Glutamax), at 200 cells/μl. Cells were acutely infected 
by LV_Pgk1p-rtTA
2S
-M2 and different combinations of LV_TREt-Xi (where Xi = Foxg1, Pax6, 
Emx2, Lhx2, Brn2 and Sox2), or, alternatively, by LV_Pgk1p-Ascl1. Each lentivirus was used at 
m.o.i. = 6 when not otherwise specified, in the presence of 9 μg/ml polybrene. 16-20 hours 
after infection, the medium was replaced by fresh MEF medium, containing 2μg/ml doxycyclin 
(for TetON system activation) plus different combinations of "epigenetic drugs" [1μM BIX-
01294, 2μM trans-2-Phenyl-cyclopropylamine hydrochloride (t2PCPA), 2 mM valproic acid 
(VPA) and 0.5 mM Na-butyrate](we refer to this TetON activation time point as day 0). 48 hours 
after doxycyclin addition (day 2), MEF medium was replaced by "neural proliferative 
medium"(1:1 DMEM-F12, 1X Glutamax, 1X N2 supplement, 6 mg/ml glucose, 1 mg/ml BSA, 2.0 
μg/ml heparin, 20 ng/ml Fgf2, 20 ng/ml Egf) supplemented with 2μg/ml doxycyclin (when not 
otherwise required), previously listed "epigenetic drugs" and different combinations of 
"signalling pathways modulators" (10μM SB431542, 0.7μM LDN193189, 25μM vitamin C, 
0.7μM BIO). Depending on cases, cells were kept in these conditions for 4 up to 15 days. During 
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this time, drugs-supplemented "neural proliferative medium" was changed every 48 hours. For 
each experimental session, appearence of NSC-like cells and reprogramming efficiency were 
assayed by FACs analysis of a dedicated batch of Sox1
+/EGFP
 fibroblasts. 
 
 7.5.2.From NSC-like cells to neuron-like cells. 
 
At day ≥6 onward, cultures containing NSC-like cells were trypsinized. When required, they 
were infected by LV_TREt-Emx2 and LV_TREt-Lhx2, or, alternatively by LV_Pgk1p-Neurog2 and 
LV_Pgk1p-Ascl1. Infections were performed at m.o.i.'s and cell densities described above, Cells 
were transferred into 2.0cm∅ wells of 12-well plates (Nunc), pre-coated with 200 μg/ml poly-L-
lysine (mw=30,000-70,000). 2,5*10
5
 cells were plated in each well, at a concentration of 500 
cells/μl. Cells were kept under "neural differentiative medium" (1:1 DMEM-F12, 1X Glutamax, 
1X N2 supplement, 1X B27 supplement, 6 mg/ml glucose, 1 mg/ml BSA, 2.0 μg/ml heparin, 5% 
heat inactivated FBS), supplemented with 2μg/ml doxycyclin (when not otherwise required), 2 
mM VPA and "signalling pathways modulators". Limited to the FPd/N protocol, an alternative 
neural differentiative medium was employed (1:1 mix of DMEM/F12/N2 and neurobasal/B27, 
supplemented with 1X glutamax, 1% FBS, 5 μM forskolin, 10�M SB431542 and 0.7μM 
LDN193189). For each experimental session, appearence of neuron-like cells and 
reprogramming efficiency were assayed by FACs analysis of a dedicated batch of Tau
+/EGFP
 
fibroblasts. 
 
7.6. FACS Sorting and Analysis. 
 
 Cultures were dissociated in  0,05% trypsin–EDTA diluted in 1X PBS,  for 10 min at 37 °C, 
pelleted and resuspended in 1X PBS.  FACS analysis and sorting of dissociated cells were 
conducted on a three lasers-equipped Cyan ADP flow cytometer (Dakocytomation, Denmark). 
Multivariate data analysis was performed by using Flowjo TM software (Tree Star, Ashland, OR). 
Forward scatter (FSC) and side scatter (SSC) were used to gate nucleated cells and to exclude 
debris and cell aggregates (live gate) in every analysis. Cells belonging to the live gate were then 
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further evaluated for the expression of the fluorochromes in use. Cells were categorized on the 
basis of their EGFP fluorescence profiles. 
 
7.7. Transplantations. 
 
 Day 13 FPd/ELv
+
-fibroblasts were dissociated by 0,05% trypsin  (Invitrogen) digestion for 
10 min at 37°C. Trypsin was inhibited by addition of 1 volume of DMEM/F12 containing soybean 
inhibitor (SIGMA), according to manifacturer's instructions. Cell suspension was centrifuged at 
100g for 7 min at RT and cells were resuspended in DMEM/F12, containing 1X pen/strept. 
50,000 cells (in 1-3μl) were injected by free-hands, with a pulled borosilicate pipette, into the 
fronto-parietal parenchyma of P0 CD1 wild-type mouse pups, preanasthetized by hypothermia. 
As a positive control, an equal amount of E12.5 cortico-cerebral precursors form Tau
EGFP
 
donors, pre-expanded in vitro in DMEM/F12/N2/Fgf2/Egf for 7 days, were injected into 
recipient pups, in the same transplantation session. Operated recipients were returned to 
mothers and allowed to develop up to P7 or P14. Their brains were fixed, crioprotected, and 
sliced at 10 μm, according to standard procedures. 
 
7.8. Immunofluorescence. 
 
 
 For immunocytofluorescence on reprogrammed fibroblasts and cortico-cerebral 
neurons, cells were fixed directly on poly-L-lysine coated 12 or 24 multiwell plates in 4% 
paraformaldehyde (PFA) for 20 min at 4°C.  Subsequently, cells were washed 3 times in 1X PBS. 
Alternatively, for immunocytofluorescence analysis on proliferating NSC-like elements, cell 
clumps were dissociated to single cells as already described and transferred 24 multiwell plates, 
previously coated with 20μg/μl poly-D-lysine.  Cells were left to attach to the well bottom one 
hour at 37°C, then they were fixed and washed 3 times in 1X PBS. Finally, as for 
immunofluorescence on brain sections, slices were allowed to dry for at least one hour at RT, 
they were post-fixed 5 minutes in 4% paraformaldeyde at RT, followed by three washes in 1X 
PBS. In all three cases, samples were subsequently treated with blocking mix (1X PBS; 10% FBS; 
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1mg/ml BSA; 0.1% Triton X100) for at least 1 hour at RT. Then, incubation with primary 
antibody was performed in blocking mix, overnight at 4°C. The day after, samples were washed 
in 1X PBS and 0,1% Triton X-100 4 times and incubated with a secondary antibody in blocking 
mix, for 2 hours at RT. Samples were finally washed in PBS for 5 minutes, 4 times, and 
counterstained with DAPI (4’, 6’-diamidino-2-phenylindole). When appropriate, they were and 
mounted in VECTASHIELD Mounting Medium (Vector). 
 The following primary antibodies were used: anti-Tubb3, mouse monoclonal, (clone 
Tuj1, Covance, MMS-435P, 1:1200); anti-GFP, chicken polyclonal (AbCam, ab 13970, 1:600); 
anti-NeuN mouse monoclonal (clone A60, Millipore, MAB 377, 1:100); anti-MAP2, rabbit 
polyclonal (Abcam, ab 32454, 1:500); anti-Sox2, rabbit polyclonal (Abcam, ab 97959,1:1000). 
Secondary antibodies were conjugates of Alexa Fluor 488, and Alexa Fluor 594 (Invitrogen, 
1:500).  
 
7.9. Quantitative RT-PCR. 
 
 In each experimental session, 500,000 FPd, day 13 cells were trypsinized, centrifuged at 
200g for 7min and processed for RNA extraction by TrizolTM (Invitrogen), according to 
manufacturer’s instructions. RNA preparations were treated by DNAseI (2U/mg of RNA) 1 hour 
at 37°C, and processed by RNeasy Mini Kit (Qiagen). At least 3.0μg of genomic DNA-free total 
RNA from each sample was retrotranscribed by SuperScriptIII
TM
 (Invitrogen) in the presence of 
random hexamers, according to manifacturer's instructions. 1/100 of the resulting cDNA was 
used as substrate of any subsequent qPCR reaction. Limited to intronless amplicons, negative 
control PCRs were run on RT- RNA preparations. PCR reactions were performed by the 
SsoAdvanced SYBR Green Supermix
TM
 platform (Biorad), according to manifacturer’s 
instructions. Per each transcript under examination and each sample, cDNA was PCR-analyzed 
at least in technical triplicate and results averaged. Averages were further normalized against 
Gapdh. Experiments were performed in biological triplicate and analyzed by Student's t test. 
 Oligos were as follows: Hes5/F 5' GCT CAG TCC CAA GGA GAA AAA CCG ACT GCG 3'; 
Hes5/R 5' CGC GGC GAA GGC TTT GCT GTG TTT CAG 3'; Neurog2/F 5' GCG ACA CAT CTG GAG 
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CCG CGT AGG AT 3'; Neurog2/R 5' GCA GCT CCT CGT CCT CCT CCT CGT 3'; Pax6/ForM 5' CCA 
AGG GCG GTG AGC AGA TGT GTG AGA TCT TCT ATT CTA G 3'; Pax6/RevM 5' CCC GTT GAC AAA 
GAC ACC ACC AAG CTG ATT CAC TC 3'; Gapdh5/F 5’ATC TTC TTG TGC AGT GCC AGC CTC GTC 3'; 
Gapdh5/R 5’GAA CAT GTA GAC CAT GTA GTT GAG GTC AAT GAA GG 3’. 
 
7.10. Electrophysiological recordings and data analysis 
 Whole cell patch clamp recordings (mainly in current-clamp mode) were performed 
from control and FPd/ELv+ cells 13-19 days after transgenes activation, at 22–24 °C, using 
a Multiclamp 700A amplifier (Axon Instruments, Foster City, CA).  
 Patch electrodes were pulled from borosilicate glass capillaries (Hilgenberg, 
Malsfeld, Germany). They had a resistance of 5-7 MΩ when filled with an intracellular 
solution containing (in mM): KMeSO4, 135; KCl, 10; EGTA, 0.5; ATP, 2; GTP 0.4 and HEPES 
10 (the pH was adjusted to 7.3–7.4 with KOH). During the experiments, cultured cells were 
superfused with an external solution containing (in mM): NaCl, 140; KCl, 5; CaCl2, 2; MgCl2, 
2; glucose 10 and HEPES 10 (pH 7.4 with NaOH). The stability of the patch was checked by 
repetitively monitoring the input and series resistance during the experiments. Cells 
exhibiting 15-20% changes were excluded from the analysis. The series resistance was 5–7 
MΩ, and it was not compensated.  
 We first measured the passive membrane properties of control and reprogrammed 
cells. The latter were recognized by their EGFP fluorescent signals. The resting membrane 
potential (RMP) was estimated immediately upon break-in by setting the clamp current 
equal to 0 and was corrected for a liquid junction potential of 10 mV. Membrane 
capacitance was measured by dividing the area underlying the capacitative transients of 
current evoked by a 5 mV, 100 ms, voltage step by the voltage step amplitude. The 
membrane input resistance (Rin) was measured by the linear part of the slope of the 
voltage/current (V/I) relationship obtained by applying hyperpolarizing and depolarizing 
voltage steps (400 ms duration) of increasing amplitude from a holding potential of -60 
mV. The depolarizing voltage steps were sub-threshold for spike generation.  
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 Single action potentials were evoked in current-clamp mode by depolarizing current 
pulses of increasing amplitude (400 ms duration) delivered at the frequency of 0.05 Hz 
from a holding potential of -70 mV. In some cases, tetrodotoxin (TTX, purchased from 
Latoxan, France) was used to block the spikes. Signals were sampled at 10 kHz, low pass-
filtered with a Butterworth filter at 3 kHz and stored on a computer hard disk. The analysis 
of traces was performed with Clampfit 10.1 software (Axon Instruments, Foster City, CA). 
Data are expressed as mean ± SEM. Unless otherwise stated, significance of differences was 
assessed by Student's t test. The differences were considered significant for p < 0.05. 
 
7.11.Images acquisitions  
Immunoprofiled cultured reprogrammed cells were photographedon a Nikon TI-E microscope, 
equipped with 20X or 40X objectives and a Hamamtsu C4742-95 camera. 
Immunoprofiled slices of transplanted brains were photographed on a 80i Nikon microscope 
equipped with a 4X objective and a DS-2MBWC digital microscope camera, as well as on aTCS 
SP2 Leica confocal microscope equipped with a 20X objective. In the latter case, they were 
collected as 6μm Z-stacks of 1024*1024 pixel images. 
All images were processed using Adobe Photoshop CS3 software. 
 
7.12. Statistical analysis of results. 
 
Generally, when not otherwise stated, experiments were performed at least in biological triplicate. 
Results were averaged and their statistical significance was evaluated by one-way and two-ways ANOVA 
(*  p<0.5; **   p<0.01; ***  p<0.001).  
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SUPPLEMENTARY MATERIALS 
 
 
 
Figure S1. Setting-up the 
"FPd" protocol: auxiliary 
tests. (A,B) FACs evaluation of 
EGFP activation (signal 
intensity and frequency of 
positive cells) in cultures of 
Trp53
-/-
Sox1
EGFP
 fibroblasts, 
following lentiviral 
transduction with different 
combinations of doxy-
activatable reprogramming 
factor genes. Each lentivirus 
was delivered at moi = 6. 
Foxg1 and Pax6 (F and P, 
respectively) were activated 
at day 0; Brn2, Sox2, Emx2 
and Lhx2 were co-activated 
with the former ones (A) or, 
alternatively, transduced at 
day 6 (B). Frequencies and 
intesities were evaluated by 
FAC sorting at day 8 (B) or 13 
(A and B). NA, not available. 
(C). FACs evaluation of EGFP 
activation (signal intensity 
and frequency of positive 
cells) in cultures of Trp53
-/-
Sox1
EGFP
 fibroblasts, upon 
delivery of the "FPd" protocol 
and inibition of the hsp90 
machinery. Such inhibition 
was achieved by keeping cells 
24 hours under different 
combinations of 1µM 17-
(allylamino)-17-
demethoxygeldanamycin and 
1µM CAY10603, and/or 
exposing them at  41°C for 2 
hours. FACs analysis was 
performed at day 8. au, 
arbitrary units. 
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Figure S2. Testing neuronogenic activities of additional drugs on FPd/ELv+ - treated fibroblasts. Plotted are 
frequencies of TauEGFP(ON) cells, evaluated at day 19, upon inclusion of neuronogenic drugs into the "neural 
prodifferentiative medium". Cells were exposed to these drugs from day 7 to day 19, or from day 7 -to day 11 
(asterisks). 
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Figure S3. Defective neuronal differentiation of reprogrammed fibroblasts in vitro. MAP2/NeuN immunoprofiling 
of FPd/ELv+ day 13 fibroblasts (A) and control E14.5 cortico-cerebral precursors, differentiated in vitro for 7 days 
(B). 
 
 
104 
 
 
 
 
Figure S4. Defective neuronal differentiation of reprogrammed fibroblasts in vivo. (A) In vivo distribution of 
derivatives of E12.5 cortico-cerebral precursors, originating from Tau
EGFP
 donors, cultured 7 days in vitro under 
"neural proliferative medium" and transplanted into parietal cortex of P0 wild type recipients. Brains were fixed 7 
days after transplantation. (B). Silhouette representing a midfrontal section of a wild type brain transplanted at P0 
with derivatives of FPd/ELv
+
-treated, IVD14 Tau
EGFP
 fibroblasts, fixed 7 days after transplantation. gm, grey matter; 
pv, periventricular region. (C, D). Distribution of �-EGFP, �-MAP2 and �-NeuN immunoreactivities, as detected by 
confocal microscopy in the two boxed regions of panel (B). 
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